Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
Defense Response To Virus (GO:0051607),21/189,6.09047135590472e-25,3.66646375625464e-22,0,0,41.8474576271186,2333.3264349521,IFITM3;GBP5;IFITM1;RSAD2;STAT1;MX2;EIF2AK2;DDX60L;IFIT1;DDX60;USP18;IFIT3;IFI44L;PML;IFIT2;IFIH1;CXCL10;IFI27;OAS2;OAS3;RIGI
Defense Response To Symbiont (GO:0140546),18/148,3.67336836839964e-22,1.10568387888829e-19,0,0,44.1960297766749,2181.32877089714,IFITM3;GBP5;IFITM1;RSAD2;STAT1;MX2;EIF2AK2;DDX60L;IFIT1;DDX60;IFIT3;IFI44L;IFIT2;IFIH1;IFI27;OAS2;OAS3;RIGI
Negative Regulation Of Viral Process (GO:0048525),10/61,4.47965335543873e-14,8.98917106658039e-12,0,0,55.6554621848739,1710.66221880087,IFITM3;IFIH1;IFITM1;RSAD2;OAS2;STAT1;OAS3;TRIM14;EIF2AK2;IFIT1
Regulation Of Viral Genome Replication (GO:0045069),9/67,5.84490330927554e-12,8.79657948045969e-10,0,0,43.408936376882,1122.79171957956,IFITM3;IFIH1;IFITM1;RSAD2;OAS2;OAS3;EIF2AK2;ADARB1;IFIT1
Antiviral Innate Immune Response (GO:0140374),8/46,1.05578368729799e-11,1.27116355950678e-09,0,0,58.1345029239766,1469.30030405123,IFIH1;CXCL10;EIF2AK2;IFIT1;USP18;IFIT3;IFIT2;RIGI
Negative Regulation Of Viral Genome Replication (GO:0045071),8/53,3.50671827593762e-11,3.51840733685741e-09,0,0,49.0740740740741,1181.39725509928,IFITM3;IFIH1;IFITM1;RSAD2;OAS2;OAS3;EIF2AK2;IFIT1
Cellular Response To Type I Interferon (GO:0071357),6/38,8.43577099691856e-09,7.25476305734996e-07,0,0,50.3918918918919,936.824813827434,IFITM3;IFITM1;IFI27;STAT1;OAS2;IFIT1
Positive Regulation Of Defense Response To Virus By Host (GO:0002230),5/28,8.24778489633693e-08,6.20645813449354e-06,0,0,57.6724637681159,940.6803354362,DTX3L;STAT1;PARP9;TRIM22;RIGI
Regulation Of Defense Response To Virus By Host (GO:0050691),5/37,3.55667713313604e-07,2.14111963414789e-05,0,0,41.4333333333333,615.254709396899,DTX3L;STAT1;PARP9;TRIM22;RIGI
Type I Interferon-Mediated Signaling Pathway (GO:0060337),5/37,3.55667713313604e-07,2.14111963414789e-05,0,0,41.4333333333333,615.254709396899,IFITM3;IFITM1;IFI27;STAT1;OAS2
Response To Interferon-Alpha (GO:0035455),4/17,5.4282790032135e-07,2.97074905448593e-05,0,0,80.5951417004049,1162.70367674071,IFITM3;IFITM1;MX2;EIF2AK2
Response To Cytokine (GO:0034097),7/125,6.84507943229177e-07,3.43394818186637e-05,0,0,16.0917111678663,228.414849593175,IFITM3;IFITM1;STAT1;MX2;EIF2AK2;XAF1;PML
Response To Type II Interferon (GO:0034341),6/80,8.0371003742747e-07,3.72179571177952e-05,0,0,21.745069393718,305.170897137451,IFITM3;GBP5;IFITM1;STAT1;CCL2;GBP4
Interferon-Mediated Signaling Pathway (GO:0140888),5/49,1.49867334216499e-06,6.44429537130946e-05,0,0,30.1151515151515,403.872197334085,IFITM3;IFITM1;IFI27;OAS2;STAT1
Response To Interferon-Beta (GO:0035456),4/29,5.22317332313206e-06,0.000209623356035033,0,0,41.8842105263158,509.412749304788,IFITM3;IFITM1;STAT1;XAF1
Positive Regulation Of Type I Interferon Production (GO:0032481),5/64,5.71817975810286e-06,0.00021514651339862,0,0,22.4418079096045,270.91436384485,IFIH1;OAS2;STAT1;OAS3;RIGI
Positive Regulation Of Interferon-Beta Production (GO:0032728),4/36,1.26815918314685e-05,0.000449077546032003,0,0,32.7105263157895,368.822929843354,IFIH1;OAS2;OAS3;RIGI
Cellular Response To Exogenous dsRNA (GO:0071360),3/14,2.17299316203163e-05,0.000726745490857246,0,0,70.5159386068477,757.116933640751,IFIH1;IFIT1;RIGI
Regulation Of Viral Entry Into Host Cell (GO:0046596),4/44,2.85246824070428e-05,0.000903782042581041,0,0,26.1578947368421,273.735588193352,IFITM3;IFITM1;TRIM22;LY6E
Regulation Of Response To Cytokine Stimulus (GO:0060759),3/16,3.32383320424404e-05,0.00100047379447746,0,0,59.6613386613387,615.216195823655,IFIH1;PARP9;RIGI
Cellular Response To dsRNA (GO:0071359),3/17,4.02445794739155e-05,0.00115367794491891,0,0,55.3970315398887,560.647609593033,IFIH1;IFIT1;RIGI
Regulation Of Interferon-Beta Production (GO:0032648),4/50,4.75191054858011e-05,0.00126038931586241,0,0,22.7391304347826,226.353915816584,IFIH1;OAS2;OAS3;RIGI
Negative Regulation Of Viral Entry Into Host Cell (GO:0046597),3/18,4.81544090777995e-05,0.00126038931586241,0,0,51.7012987012987,513.96766958297,IFITM3;IFITM1;LY6E
Negative Regulation Of Viral Life Cycle (GO:1903901),3/20,6.68876617521441e-05,0.00167776551561628,0,0,45.6142093200917,438.466406277307,IFITM3;IFITM1;LY6E
Cytokine-Mediated Signaling Pathway (GO:0019221),7/257,7.61951913304844e-05,0.00180162253642683,0,0,7.54465753424657,71.5400437399117,CXCL10;CXCL9;OAS2;STAT1;IL31RA;CCL2;BIRC3
Positive Regulation Of Interferon-Alpha Production (GO:0032727),3/21,7.78109401114577e-05,0.00180162253642683,0,0,43.0779220779221,407.570064871301,IFIH1;STAT1;RIGI
Cytosolic Pattern Recognition Receptor Signaling Pathway (GO:0002753),3/23,0.000103015785317148,0.00229687047262678,0,0,38.7662337662338,355.89838380549,IFIH1;OAS3;RIGI
Cellular Response To Type II Interferon (GO:0071346),4/66,0.000141672205805129,0.00304443229017159,0,0,16.8573853989813,149.390058016348,GBP5;STAT1;CCL2;GBP4
Regulation Of Interferon-Alpha Production (GO:0032647),3/26,0.000149935373709333,0.00304443229017159,0,0,33.7046866177301,296.780085998481,IFIH1;STAT1;RIGI
Interleukin-27-Mediated Signaling Pathway (GO:0070106),2/5,0.000156773091354351,0.00304443229017159,0,0,170.230769230769,1491.34258548202,OAS2;STAT1
Regulation Of Ribonuclease Activity (GO:0060700),2/5,0.000156773091354351,0.00304443229017159,0,0,170.230769230769,1491.34258548202,OAS2;OAS3
RIG-I Signaling Pathway (GO:0039529),2/6,0.000234549448003858,0.0042787505363128,0,0,127.666666666667,1067.01810016501,OAS3;RIGI
Regulation Of Nuclease Activity (GO:0032069),2/6,0.000234549448003858,0.0042787505363128,0,0,127.666666666667,1067.01810016501,OAS2;OAS3
Positive Regulation Of Tumor Necrosis Factor Production (GO:0032760),4/78,0.000270392355380166,0.00478753523349588,0,0,14.1152204836415,115.965520409362,IFIH1;OAS2;OAS3;RIGI
Positive Regulation Of Apoptotic Cell Clearance (GO:2000427),2/7,0.000327517205344795,0.0054776018138456,0,0,102.128205128205,819.473650922797,CCL2;C2
Positive Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),4/82,0.000327564228070501,0.0054776018138456,0,0,13.3886639676113,107.428315482659,IFIH1;OAS2;OAS3;RIGI
Protein Ubiquitination (GO:0016567),8/434,0.000341180874956535,0.00555110504659011,0,0,5.08450704225352,40.5901169638484,HERC5;RNF144A;RNF213;DTX3L;TRIM14;BRCA2;TRIM22;HERC6
Response To Exogenous dsRNA (GO:0043330),3/35,0.000367778743515282,0.00582638956832105,0,0,24.2142857142857,191.487274637107,IFIH1;IFIT1;RIGI
Positive Regulation Of Chromatin Binding (GO:0035563),2/8,0.000435556653661913,0.00672320783344799,0,0,85.1025641025641,658.599014780066,DTX3L;PARP9
Protein Modification By Small Protein Conjugation (GO:0032446),7/364,0.00063468393475568,0.00955199321807298,0,0,5.25463336019339,38.6866255478038,IFIH1;HERC5;RNF144A;RNF213;TRIM14;PML;HERC6
Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),7/367,0.000666145026588803,0.00978095868308437,0,0,5.21004566210046,38.1062904024233,HERC5;RNF144A;RNF213;DTX3L;IFI27;PML;HERC6
Regulation Of Chromatin Binding (GO:0035561),2/10,0.000696375227782124,0.00998137826487711,0,0,63.8205128205128,463.950999106878,DTX3L;PARP9
Regulation Of Type II Interferon-Mediated Signaling Pathway (GO:0060334),2/11,0.000848918370675252,0.0118848571894535,0,0,56.7264957264957,401.144110393655,PARP14;PARP9
Modification-Dependent Protein Catabolic Process (GO:0019941),5/192,0.00103911507823544,0.0141121979840532,0,0,7.0349376114082,48.325700632646,HERC5;RNF144A;RNF213;DTX3L;HERC6
Blood Circulation (GO:0008015),3/50,0.00105489852040265,0.0141121979840532,0,0,16.4738878143133,112.917145612989,CXCL10;STAT1;SERPING1
Negative Regulation Of Innate Immune Response (GO:0045824),3/52,0.00118264359025057,0.0153405934136945,0,0,15.7998939835675,106.491333095133,OAS3;SERPING1;USP18
Negative Regulation Of Viral Transcription (GO:0032897),2/13,0.00119768752565389,0.0153405934136945,0,0,46.4079254079254,312.202943743075,IFITM3;TRIM14
Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042531),3/55,0.00139188917577042,0.017122374364154,0,0,14.8861138861139,97.9073604295734,IL31RA;PARP9;PARP14
Positive Regulation Of Response To Cytokine Stimulus (GO:0060760),2/14,0.00139368163429161,0.017122374364154,0,0,42.5384615384615,279.724686592331,IFIH1;RIGI
Cellular Response To Cytokine Stimulus (GO:0071345),6/308,0.00146899844219356,0.0176867412440105,0,0,5.2670485054591,34.3578761968736,GBP5;STAT1;IL31RA;CCL2;IFIT1;GBP4
Chemokine-Mediated Signaling Pathway (GO:0070098),3/57,0.00154350091845407,0.018218208061047,0,0,14.3333333333333,92.7897303719875,CXCL10;CXCL9;CCL2
Negative Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060339),2/15,0.00160392861667025,0.018218208061047,0,0,39.2642998027613,252.677520008974,OAS3;USP18
Defense Response To Protozoan (GO:0042832),2/15,0.00160392861667025,0.018218208061047,0,0,39.2642998027613,252.677520008974,BATF2;GBP4
Regulation Of Tumor Necrosis Factor Production (GO:0032680),4/127,0.00168973757587822,0.0183296606973672,0,0,8.47111681643132,54.0726807438337,IFIH1;OAS2;OAS3;RIGI
Cellular Response To Chemokine (GO:1990869),3/59,0.00170508471603416,0.0183296606973672,0,0,13.8200371057514,88.0908579875981,CXCL10;CXCL9;CCL2
Negative Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001960),3/59,0.00170508471603416,0.0183296606973672,0,0,13.8200371057514,88.0908579875981,OAS3;PARP14;USP18
Regulation Of Nucleocytoplasmic Transport (GO:0046822),2/16,0.00182831419978963,0.0193095640047957,0,0,36.4578754578755,229.843605955453,IFI27;MX2
Regulation Of Viral Transcription (GO:0046782),2/17,0.0020667247756085,0.0214511778433848,0,0,34.025641025641,210.339372837963,IFITM3;TRIM14
Protein Polyubiquitination (GO:0000209),5/226,0.00213029805535722,0.0217362615139838,0,0,5.94238310708899,36.5545303266038,RNF144A;RNF213;DTX3L;IFI27;TRIM22
Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),3/65,0.00225195207566845,0.0225945858258734,0,0,12.4788437369083,76.0705054334075,IL31RA;PARP9;PARP14
Regulation Of RIG-I Signaling Pathway (GO:0039535),2/18,0.00231904739957858,0.0228863366319067,0,0,31.8974358974359,193.508945740531,DDX60;BIRC3
Inflammatory Response (GO:0006954),5/236,0.0025695513882964,0.0249495150928134,0,0,5.68225108225108,33.8890815580678,CXCL10;CXCL9;BLNK;CCL2;SIGLEC1
Neutrophil Chemotaxis (GO:0030593),3/70,0.00278205261143903,0.026584058287084,0,0,11.5446792013956,67.9354298759945,CXCL10;CXCL9;CCL2
Protein Autoubiquitination (GO:0051865),3/71,0.0028964910526098,0.0272451189636109,0,0,11.3743315508021,66.4744969545793,RNF213;DTX3L;BRCA2
Granulocyte Chemotaxis (GO:0071621),3/73,0.00313397741749017,0.0290254523896782,0,0,11.0482374768089,63.6980866215551,CXCL10;CXCL9;CCL2
Regulation Of Cell Population Proliferation (GO:0042127),9/766,0.00345877708622345,0.0315482394834321,0,0,3.20886747167284,18.1841391710739,CXCL10;CXCL9;IFITM1;STAT1;IL31RA;EIF2AK2;ADARB1;IFIT3;PML
Positive Regulation Of Response To Stimulus (GO:0048584),3/77,0.00364402281486878,0.0317927787616088,0,0,10.4489294489294,58.6672597662202,IFIH1;RSAD2;RIGI
Neutrophil Migration (GO:1990266),3/77,0.00364402281486878,0.0317927787616088,0,0,10.4489294489294,58.6672597662202,CXCL10;CXCL9;CCL2
Negative Regulation Of Blood Vessel Morphogenesis (GO:2000181),3/77,0.00364402281486878,0.0317927787616088,0,0,10.4489294489294,58.6672597662202,CXCL10;STAT1;PML
Regulation Of Innate Immune Response (GO:0045088),3/78,0.00377896854962841,0.0324991295268043,0,0,10.3090909090909,57.507244879824,GBP5;PARP9;BIRC3
Regulation Of Cytokine Production (GO:0001817),4/167,0.00453180098777795,0.0384245661217229,0,0,6.37939941879238,34.4272956014213,IFIH1;EIF2AK2;IGF2BP3;RIGI
Negative Regulation Of Catalytic Activity (GO:0043086),2/26,0.00482512460775433,0.0403434029703903,0,0,21.2564102564103,113.379964567182,IFIT1;PARP9
Negative Regulation Of Angiogenesis (GO:0016525),3/86,0.0049687742153235,0.0409753709263664,0,0,9.31168831168831,49.3946151952901,CXCL10;STAT1;PML
Integrated Stress Response Signaling (GO:0140467),2/29,0.0059811421098148,0.0480086340014468,0,0,18.8917378917379,96.709521784955,BATF2;EIF2AK2
Positive Regulation Of Viral Genome Replication (GO:0045070),2/29,0.0059811421098148,0.0480086340014468,0,0,18.8917378917379,96.709521784955,ADARB1;IFIT1
Regulation Of Response To Biotic Stimulus (GO:0002831),2/31,0.00681503274729453,0.0532811651152118,0,0,17.5870910698497,87.7353917884882,HERC5;BIRC3
Receptor Signaling Pathway Via STAT (GO:0097696),2/31,0.00681503274729453,0.0532811651152118,0,0,17.5870910698497,87.7353917884882,STAT1;IL31RA
Regulation Of Defense Response (GO:0031347),3/97,0.00693742832154731,0.0535427160201472,0,0,8.21746338767615,40.8475653112228,HERC5;USP18;BIRC3
Positive Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051281),2/33,0.0076985180810773,0.0572161467260313,0,0,16.4507857733664,80.0614902966969,CXCL10;CXCL9
Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060338),2/33,0.0076985180810773,0.0572161467260313,0,0,16.4507857733664,80.0614902966969,OAS3;USP18
Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900225),2/33,0.0076985180810773,0.0572161467260313,0,0,16.4507857733664,80.0614902966969,GBP5;EIF2AK2
DNA Damage Checkpoint Signaling (GO:0000077),2/34,0.00815860063481851,0.059896068075131,0,0,15.9358974358974,76.630672963083,DTX3L;PARP9
Defense Response To Bacterium (GO:0042742),4/204,0.00909298314165119,0.0653236979026822,0,0,5.18947368421053,24.3918353409725,RNF213;OAS2;OAS3;GBP4
Receptor Signaling Pathway Via JAK-STAT (GO:0007259),2/36,0.00911493459107193,0.0653236979026822,0,0,14.9969834087481,70.4534442364409,STAT1;IL31RA
Negative Regulation Of Endothelial Cell Proliferation (GO:0001937),2/37,0.00961098343707057,0.0680683768131351,0,0,14.5677655677656,67.6650673449927,STAT1;CCL2
Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0033209),2/38,0.0101188194904489,0.070831736433142,0,0,14.1623931623932,65.0529457989275,STAT1;BIRC3
Positive Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062208),2/39,0.0106383429632722,0.0736124421136768,0,0,13.7789327789328,62.6016949972359,RSAD2;DDX60
Cellular Response To Molecule Of Bacterial Origin (GO:0071219),3/117,0.0115630994247563,0.0791021119739011,0,0,6.76896787423103,30.1891657750745,CXCL10;CXCL9;CCL2
Positive Regulation Of Viral Process (GO:0048524),2/41,0.0117120559925051,0.0791370183388179,0,0,13.0710059171598,58.1285480417471,ADARB1;IFIT1
Regulation Of Protein Binding (GO:0043393),3/118,0.0118311156984944,0.0791370183388179,0,0,6.70976849237719,29.7713923915614,DTX3L;IFIT1;IFIT2
Cellular Response To Tumor Necrosis Factor (GO:0071356),3/119,0.0121026970781126,0.079399585524148,0,0,6.65158978952082,29.3622920828612,STAT1;CCL2;BIRC3
DNA Integrity Checkpoint Signaling (GO:0031570),2/42,0.012266048926488,0.079399585524148,0,0,12.7435897435897,56.0835200320403,DTX3L;PARP9
Positive Regulation Of Calcium Ion Transmembrane Transport (GO:1904427),2/42,0.012266048926488,0.079399585524148,0,0,12.7435897435897,56.0835200320403,CXCL10;CXCL9
Lymphocyte Chemotaxis (GO:0048247),2/44,0.0134078204637278,0.0847461355975125,0,0,12.1355311355311,52.3274045311501,CXCL10;CCL2
Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),2/44,0.0134078204637278,0.0847461355975125,0,0,12.1355311355311,52.3274045311501,PARP14;PARP9
Cellular Response To Lipopolysaccharide (GO:0071222),3/124,0.0135143339158824,0.0847461355975125,0,0,6.37512074702157,27.438547651817,CXCL10;CXCL9;CCL2
Regulation Of Response To External Stimulus (GO:0032101),3/127,0.0144045370561648,0.0887432932951313,0,0,6.21994134897361,26.3738702500045,HERC5;USP18;BIRC3
B Cell Receptor Signaling Pathway (GO:0050853),2/46,0.0145939967379037,0.0887432932951313,0,0,11.5827505827506,48.9619664109026,BLNK;CD38
Protein Sumoylation (GO:0016925),2/46,0.0145939967379037,0.0887432932951313,0,0,11.5827505827506,48.9619664109026,IFIH1;PML
Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),3/130,0.0153273481073232,0.0922706356060855,0,0,6.07209326106964,25.3699135791161,IL31RA;PARP9;PARP14
Post-Translational Protein Modification (GO:0043687),2/48,0.0158238144083772,0.0933915320965009,0,0,11.0780379041249,45.9321953789812,PARP9;PARP12
Cellular Defense Response (GO:0006968),2/48,0.0158238144083772,0.0933915320965009,0,0,11.0780379041249,45.9321953789812,LGALS3BP;CXCL9
Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),4/246,0.0170523184548046,0.0996650068911881,0,0,4.27968682035668,17.4246126670584,TRIM14;EIF2AK2;TRIM22;RIGI
Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051279),2/51,0.0177487210552944,0.101230159971683,0,0,10.3982208267923,41.9198222830743,CXCL10;CXCL9
Negative Regulation Of Cell Population Proliferation (GO:0008285),5/379,0.0179697289898104,0.101230159971683,0,0,3.48413547237077,14.0029727143869,IFITM1;EIF2AK2;ADARB1;IFIT3;PML
Regulation Of Protein Localization To Nucleus (GO:1900180),2/52,0.0184113659012514,0.101230159971683,0,0,10.1897435897436,40.7058561737784,DTX3L;PARP9
Positive Regulation Of Chemokine Production (GO:0032722),2/53,0.0190843619934294,0.101230159971683,0,0,9.9894419306184,39.5470620375227,OAS3;EIF2AK2
Protein K63-linked Ubiquitination (GO:0070534),2/54,0.0197676181154707,0.101230159971683,0,0,9.79684418145957,38.4399767450819,RNF213;TRIM22
CD4-positive, Alpha-Beta T Cell Activation (GO:0035710),1/5,0.0198424566057452,0.101230159971683,0,0,63.0253164556962,247.054914696706,RSAD2
Establishment Of Protein Localization To Telomere (GO:0070200),1/5,0.0198424566057452,0.101230159971683,0,0,63.0253164556962,247.054914696706,BRCA2
Positive Regulation Of Interleukin-18 Production (GO:0032741),1/5,0.0198424566057452,0.101230159971683,0,0,63.0253164556962,247.054914696706,GBP5
PML Body Organization (GO:0030578),1/5,0.0198424566057452,0.101230159971683,0,0,63.0253164556962,247.054914696706,PML
Regulation Of Hematopoietic Stem Cell Proliferation (GO:1902033),1/5,0.0198424566057452,0.101230159971683,0,0,63.0253164556962,247.054914696706,EIF2AK2
Negative Regulation Of Protein Kinase Activity By Regulation Of Protein Phosphorylation (GO:0044387),1/5,0.0198424566057452,0.101230159971683,0,0,63.0253164556962,247.054914696706,ADARB1
Positive Regulation Of Toll-Like Receptor 7 Signaling Pathway (GO:0034157),1/5,0.0198424566057452,0.101230159971683,0,0,63.0253164556962,247.054914696706,RSAD2
Attachment Of GPI Anchor To Protein (GO:0016255),1/5,0.0198424566057452,0.101230159971683,0,0,63.0253164556962,247.054914696706,PGAP1
Mesenchymal Cell Differentiation Involved In Kidney Development (GO:0072161),1/5,0.0198424566057452,0.101230159971683,0,0,63.0253164556962,247.054914696706,STAT1
Detection Of Virus (GO:0009597),1/5,0.0198424566057452,0.101230159971683,0,0,63.0253164556962,247.054914696706,RIGI
Pattern Recognition Receptor Signaling Pathway (GO:0002221),2/56,0.0211645483155655,0.107067715008155,0,0,9.43304843304843,36.3684366613391,IFIH1;RIGI
Signal Transduction In Response To DNA Damage (GO:0042770),2/57,0.0218780426930727,0.10824963644514,0,0,9.26107226107226,35.3983349881409,DTX3L;PARP9
Regulation Of Apoptotic Process (GO:0042981),7/705,0.022647024632006,0.10824963644514,0,0,2.64069552930094,10.0022332230315,CXCL10;STAT1;IL31RA;CD38;IFIT3;IFIT2;BIRC3
Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),3/152,0.0231008764939404,0.10824963644514,0,0,5.16978994160202,19.4791725199215,TRIM14;EIF2AK2;TRIM22
Regulation Of Hemoglobin Biosynthetic Process (GO:0046984),1/6,0.0237640515542399,0.10824963644514,0,0,50.4177215189873,188.541167525517,EIF2AK2
Negative Regulation Of Response To Type II Interferon (GO:0060331),1/6,0.0237640515542399,0.10824963644514,0,0,50.4177215189873,188.541167525517,PARP14
Adenosine To Inosine Editing (GO:0006382),1/6,0.0237640515542399,0.10824963644514,0,0,50.4177215189873,188.541167525517,ADARB1
Positive Regulation Of Receptor Catabolic Process (GO:2000646),1/6,0.0237640515542399,0.10824963644514,0,0,50.4177215189873,188.541167525517,DTX3L
Negative Regulation Of Type II Interferon-Mediated Signaling Pathway (GO:0060336),1/6,0.0237640515542399,0.10824963644514,0,0,50.4177215189873,188.541167525517,PARP14
Interleukin-9-Mediated Signaling Pathway (GO:0038113),1/6,0.0237640515542399,0.10824963644514,0,0,50.4177215189873,188.541167525517,STAT1
Macrophage Derived Foam Cell Differentiation (GO:0010742),1/6,0.0237640515542399,0.10824963644514,0,0,50.4177215189873,188.541167525517,STAT1
Cellular Response To Interleukin-9 (GO:0071355),1/6,0.0237640515542399,0.10824963644514,0,0,50.4177215189873,188.541167525517,STAT1
Regulation Of Toll-Like Receptor 7 Signaling Pathway (GO:0034155),1/6,0.0237640515542399,0.10824963644514,0,0,50.4177215189873,188.541167525517,RSAD2
Regulation Of MDA-5 Signaling Pathway (GO:0039533),1/6,0.0237640515542399,0.10824963644514,0,0,50.4177215189873,188.541167525517,DDX60
Positive Regulation Of Phagocytosis (GO:0050766),2/60,0.0240775760407768,0.10824963644514,0,0,8.78072502210433,32.7211463617583,CCL2;C2
Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),6/557,0.0240954340259946,0.10824963644514,0,0,2.85019865600628,10.6190789496435,DTX3L;STAT1;IL31RA;CD38;BRCA2;PARP9
Response To Lipopolysaccharide (GO:0032496),3/159,0.0259477538327855,0.115576472797628,0,0,4.93606393606394,18.0248777317617,CXCL10;CXCL9;CCL2
Positive Regulation Of DNA-templated Transcription (GO:0045893),10/1243,0.0261102995024541,0.115576472797628,0,0,2.16510253736531,7.89271983861704,CXCL10;DTX3L;STAT1;IL31RA;CD38;NCOA7;BRCA2;PARP9;AGRN;RIGI
Cellular Response To Virus (GO:0098586),2/64,0.0271448016014955,0.117305860137913,0,0,8.2125723738627,29.6192148509306,IFIH1;CXCL10
Regulation Of Chemokine (C-C Motif) Ligand 5 Production (GO:0071649),1/7,0.0276701530557868,0.117305860137913,0,0,42.0126582278481,150.716250195238,OAS3
Foam Cell Differentiation (GO:0090077),1/7,0.0276701530557868,0.117305860137913,0,0,42.0126582278481,150.716250195238,STAT1
Negative Regulation Of Osteoblast Proliferation (GO:0033689),1/7,0.0276701530557868,0.117305860137913,0,0,42.0126582278481,150.716250195238,EIF2AK2
Positive Regulation Of T-helper 2 Cell Cytokine Production (GO:2000553),1/7,0.0276701530557868,0.117305860137913,0,0,42.0126582278481,150.716250195238,RSAD2
Regulation Of Apoptotic Cell Clearance (GO:2000425),1/7,0.0276701530557868,0.117305860137913,0,0,42.0126582278481,150.716250195238,CCL2
Antimicrobial Humoral Immune Response Mediated By Antimicrobial Peptide (GO:0061844),2/65,0.0279350525070476,0.117600710554145,0,0,8.08180708180708,28.9156794822143,CXCL10;CXCL9
Double-Strand Break Repair (GO:0006302),3/168,0.0298728281853988,0.124885017830626,0,0,4.66469893742621,16.3768528688872,DTX3L;BRCA2;PARP9
Regulation Of Endopeptidase Activity (GO:0052548),2/69,0.0311872894154663,0.124997463114986,0,0,7.59778032912361,26.347162146717,SERPING1;BIRC3
Positive Regulation Of Monocyte Chemotactic Protein-1 Production (GO:0071639),1/8,0.0315608212516243,0.124997463114986,0,0,36.0090415913201,124.441441693173,OAS3
Regulation Of Helicase Activity (GO:0051095),1/8,0.0315608212516243,0.124997463114986,0,0,36.0090415913201,124.441441693173,IFIT1
Regulation Of Interleukin-18 Production (GO:0032661),1/8,0.0315608212516243,0.124997463114986,0,0,36.0090415913201,124.441441693173,GBP5
Regulation Of Morphogenesis Of An Epithelium (GO:1905330),1/8,0.0315608212516243,0.124997463114986,0,0,36.0090415913201,124.441441693173,CXCL10
Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062207),1/8,0.0315608212516243,0.124997463114986,0,0,36.0090415913201,124.441441693173,BIRC3
Protein poly-ADP-ribosylation (GO:0070212),1/8,0.0315608212516243,0.124997463114986,0,0,36.0090415913201,124.441441693173,PARP9
Positive Regulation Of Dendritic Cell Cytokine Production (GO:0002732),1/8,0.0315608212516243,0.124997463114986,0,0,36.0090415913201,124.441441693173,RIGI
Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),2/70,0.0320227392479154,0.125179798878215,0,0,7.48567119155354,25.7605078449671,STAT1;BRCA2
Protein K48-linked Ubiquitination (GO:0070936),2/70,0.0320227392479154,0.125179798878215,0,0,7.48567119155354,25.7605078449671,DTX3L;IFI27
Negative Regulation Of Protein Binding (GO:0032091),2/71,0.0328669800118058,0.126832833122482,0,0,7.3768115942029,25.1939270591305,IFIT1;IFIT2
Myeloid Leukocyte Differentiation (GO:0002573),2/71,0.0328669800118058,0.126832833122482,0,0,7.3768115942029,25.1939270591305,BATF2;IL31RA
Positive Regulation Of Protein Localization To Nucleus (GO:1900182),2/72,0.0337199299235671,0.126979416107207,0,0,7.27106227106227,24.6464741930871,DTX3L;PARP9
Positive Regulation Of Mesenchymal Cell Proliferation (GO:0002053),1/9,0.0354361161229415,0.126979416107207,0,0,31.506329113924,105.231887498846,STAT1
NAD Biosynthesis Via Nicotinamide Riboside Salvage Pathway (GO:0034356),1/9,0.0354361161229415,0.126979416107207,0,0,31.506329113924,105.231887498846,PARP9
Negative Regulation Of Necroptotic Process (GO:0060546),1/9,0.0354361161229415,0.126979416107207,0,0,31.506329113924,105.231887498846,BIRC3
Type II Interferon-Mediated Signaling Pathway (GO:0060333),1/9,0.0354361161229415,0.126979416107207,0,0,31.506329113924,105.231887498846,STAT1
Negative Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042532),1/9,0.0354361161229415,0.126979416107207,0,0,31.506329113924,105.231887498846,PARP14
Cell Differentiation Involved In Metanephros Development (GO:0072202),1/9,0.0354361161229415,0.126979416107207,0,0,31.506329113924,105.231887498846,STAT1
Positive Regulation Of RIG-I Signaling Pathway (GO:1900246),1/9,0.0354361161229415,0.126979416107207,0,0,31.506329113924,105.231887498846,DDX60
Regulation Of Viral-Induced Cytoplasmic Pattern Recognition Receptor Signaling Pathway (GO:0039531),1/9,0.0354361161229415,0.126979416107207,0,0,31.506329113924,105.231887498846,BIRC3
Regulation Of ER To Golgi Vesicle-Mediated Transport (GO:0060628),1/9,0.0354361161229415,0.126979416107207,0,0,31.506329113924,105.231887498846,PGAP1
Myeloid Dendritic Cell Differentiation (GO:0043011),1/9,0.0354361161229415,0.126979416107207,0,0,31.506329113924,105.231887498846,BATF2
Response To Type I Interferon (GO:0034340),1/9,0.0354361161229415,0.126979416107207,0,0,31.506329113924,105.231887498846,IFIT1
Positive Regulation Of Interleukin-6 Production (GO:0032755),2/76,0.0372172030722745,0.130477010675302,0,0,6.87664587664588,22.6309327668842,IFIH1;RIGI
Regulation Of Immune Response (GO:0050776),2/77,0.0381124895191706,0.130477010675302,0,0,6.78461538461538,22.1667852242192,RSAD2;BIRC3
CRD-mediated mRNA Stabilization (GO:0070934),1/10,0.03929609749471,0.130477010675302,0,0,28.0042194092827,90.6392984988873,IGF2BP3
T Cell Chemotaxis (GO:0010818),1/10,0.03929609749471,0.130477010675302,0,0,28.0042194092827,90.6392984988873,CXCL10
Negative Regulation Of Programmed Necrotic Cell Death (GO:0062099),1/10,0.03929609749471,0.130477010675302,0,0,28.0042194092827,90.6392984988873,BIRC3
Regulation Of Programmed Necrotic Cell Death (GO:0062098),1/10,0.03929609749471,0.130477010675302,0,0,28.0042194092827,90.6392984988873,BIRC3
Protein auto-ADP-ribosylation (GO:0070213),1/10,0.03929609749471,0.130477010675302,0,0,28.0042194092827,90.6392984988873,PARP12
Metanephric Mesenchyme Development (GO:0072075),1/10,0.03929609749471,0.130477010675302,0,0,28.0042194092827,90.6392984988873,STAT1
Regulation Of Toll-Like Receptor 9 Signaling Pathway (GO:0034163),1/10,0.03929609749471,0.130477010675302,0,0,28.0042194092827,90.6392984988873,RSAD2
Receptor-Mediated Endocytosis Of Virus By Host Cell (GO:0019065),1/10,0.03929609749471,0.130477010675302,0,0,28.0042194092827,90.6392984988873,SIGLEC1
Monocyte Differentiation (GO:0030224),1/10,0.03929609749471,0.130477010675302,0,0,28.0042194092827,90.6392984988873,IL31RA
Regulation Of T-helper 2 Cell Cytokine Production (GO:2000551),1/10,0.03929609749471,0.130477010675302,0,0,28.0042194092827,90.6392984988873,RSAD2
Endosomal Vesicle Fusion (GO:0034058),1/10,0.03929609749471,0.130477010675302,0,0,28.0042194092827,90.6392984988873,SAMD9
Positive Regulation Of Cytokine Production (GO:0001819),4/320,0.0394465381111379,0.130477010675302,0,0,3.26515656229181,10.5556274863024,IFIH1;GBP5;EIF2AK2;RIGI
Positive Regulation Of Immune Response (GO:0050778),2/80,0.0408474093843072,0.134372352182256,0,0,6.52268244575937,20.8589636661411,GBP5;RSAD2
Histone H2A Ubiquitination (GO:0033522),1/11,0.0431408249946983,0.138142428972385,0,0,25.2025316455696,79.2187526513519,BRCA2
Regulation Of Mesenchymal Cell Proliferation (GO:0010464),1/11,0.0431408249946983,0.138142428972385,0,0,25.2025316455696,79.2187526513519,STAT1
Regulation Of Monocyte Chemotactic Protein-1 Production (GO:0071637),1/11,0.0431408249946983,0.138142428972385,0,0,25.2025316455696,79.2187526513519,OAS3
Macrophage Chemotaxis (GO:0048246),1/11,0.0431408249946983,0.138142428972385,0,0,25.2025316455696,79.2187526513519,CCL2
Regulation Of Cell Cycle Checkpoint (GO:1901976),1/11,0.0431408249946983,0.138142428972385,0,0,25.2025316455696,79.2187526513519,BRCA2
Regulation Of Programmed Cell Death (GO:0043067),3/195,0.0434146557643851,0.138283718360634,0,0,4.00324675324675,12.5580177470622,CXCL10;STAT1;BIRC3
Negative Regulation Of Apoptotic Process (GO:0043066),5/482,0.0439355432203752,0.139206300098242,0,0,2.71740041928721,8.49196230493022,IL31RA;CD38;CCL2;IFIT3;BIRC3
Positive Regulation Of Protein Localization (GO:1903829),2/85,0.0455645014385399,0.139980968036858,0,0,6.12820512820513,18.9277357934091,DTX3L;PARP9
Negative Regulation Of Gene Expression (GO:0010629),4/336,0.0457833613355449,0.139980968036858,0,0,3.10526315789474,9.57611779292581,EIF2AK2;IGF2BP3;PARP9;PARP14
Negative Regulation Of Binding (GO:0051100),2/86,0.0465310679425488,0.139980968036858,0,0,6.05494505494505,18.5743617471565,IFIT1;IFIT2
Regulation Of Chemokine (C-X-C Motif) Ligand 2 Production (GO:2000341),1/12,0.0469703580455903,0.139980968036858,0,0,22.9102416570771,70.0649843655932,OAS3
Positive Regulation Of Myeloid Leukocyte Mediated Immunity (GO:0002888),1/12,0.0469703580455903,0.139980968036858,0,0,22.9102416570771,70.0649843655932,RIGI
Regulation Of Hematopoietic Stem Cell Differentiation (GO:1902036),1/12,0.0469703580455903,0.139980968036858,0,0,22.9102416570771,70.0649843655932,EIF2AK2
Histone Monoubiquitination (GO:0010390),1/12,0.0469703580455903,0.139980968036858,0,0,22.9102416570771,70.0649843655932,BRCA2
Nuclear Body Organization (GO:0030575),1/12,0.0469703580455903,0.139980968036858,0,0,22.9102416570771,70.0649843655932,PML
Lipid Droplet Formation (GO:0140042),1/12,0.0469703580455903,0.139980968036858,0,0,22.9102416570771,70.0649843655932,RNF213
Macrophage Migration (GO:1905517),1/12,0.0469703580455903,0.139980968036858,0,0,22.9102416570771,70.0649843655932,CCL2
Dendrite Self-Avoidance (GO:0070593),1/12,0.0469703580455903,0.139980968036858,0,0,22.9102416570771,70.0649843655932,NEXN
Negative Regulation Of Complement Activation (GO:0045916),1/12,0.0469703580455903,0.139980968036858,0,0,22.9102416570771,70.0649843655932,SERPING1
Regulation Of Translation (GO:0006417),3/202,0.0473497791532127,0.140416586454355,0,0,3.8610585394505,11.7769742064467,SAMD4A;EIF2AK2;IGF2BP3
Regulation Of Angiogenesis (GO:0045765),3/205,0.0490885613435232,0.144859382003926,0,0,3.8031374566028,11.4631478035075,CXCL10;STAT1;PML
Positive Regulation Of Granulocyte Macrophage Colony-Stimulating Factor Production (GO:0032725),1/13,0.0507847558615242,0.144893000135723,0,0,21,62.5833400688415,RIGI
Substrate-Dependent Cell Migration (GO:0006929),1/13,0.0507847558615242,0.144893000135723,0,0,21,62.5833400688415,CD2AP
Suppression Of Viral Release By Host (GO:0044790),1/13,0.0507847558615242,0.144893000135723,0,0,21,62.5833400688415,PML
Negative Regulation Of Translational Initiation (GO:0045947),1/13,0.0507847558615242,0.144893000135723,0,0,21,62.5833400688415,EIF2AK2
Positive Regulation Of Type 2 Immune Response (GO:0002830),1/13,0.0507847558615242,0.144893000135723,0,0,21,62.5833400688415,RSAD2
Myeloid Dendritic Cell Activation (GO:0001773),1/13,0.0507847558615242,0.144893000135723,0,0,21,62.5833400688415,BATF2
Regulation Of T Cell Chemotaxis (GO:0010819),1/13,0.0507847558615242,0.144893000135723,0,0,21,62.5833400688415,CXCL10
Regulation Of RNA Metabolic Process (GO:0051252),2/91,0.0514755401032426,0.14548485982231,0,0,5.71333909536157,16.9494690491469,OAS2;OAS3
Positive Regulation Of Binding (GO:0051099),2/91,0.0514755401032426,0.14548485982231,0,0,5.71333909536157,16.9494690491469,DTX3L;PARP9
Negative Regulation Of Amide Metabolic Process (GO:0034249),2/93,0.0535040634957514,0.150511430955338,0,0,5.58720766413074,16.3593310490479,EIF2AK2;IGF2BP3
Peptidyl-Lysine Modification (GO:0018205),2/94,0.0545289086681384,0.150732177194295,0,0,5.52619843924192,16.0758454561102,IFIH1;PML
Establishment Of Protein Localization To Chromosome (GO:0070199),1/14,0.0545840774557414,0.150732177194295,0,0,19.3836416747809,56.3678831493627,BRCA2
Histone H2A Monoubiquitination (GO:0035518),1/14,0.0545840774557414,0.150732177194295,0,0,19.3836416747809,56.3678831493627,BRCA2
Regulation Of Non-Canonical Wnt Signaling Pathway (GO:2000050),1/14,0.0545840774557414,0.150732177194295,0,0,19.3836416747809,56.3678831493627,RNF213
Negative Regulation Of Macrophage Activation (GO:0043031),1/15,0.0583683815937167,0.156352707551765,0,0,17.998191681736,51.1325196452123,IL31RA
Regulation Of Granulocyte Macrophage Colony-Stimulating Factor Production (GO:0032645),1/15,0.0583683815937167,0.156352707551765,0,0,17.998191681736,51.1325196452123,RIGI
Alpha-Beta T Cell Activation (GO:0046631),1/15,0.0583683815937167,0.156352707551765,0,0,17.998191681736,51.1325196452123,RSAD2
Cardiac Myofibril Assembly (GO:0055003),1/15,0.0583683815937167,0.156352707551765,0,0,17.998191681736,51.1325196452123,NEBL
Protein Localization To Chromosome, Telomeric Region (GO:0070198),1/15,0.0583683815937167,0.156352707551765,0,0,17.998191681736,51.1325196452123,BRCA2
Positive Regulation Of Endothelial Cell Apoptotic Process (GO:2000353),1/15,0.0583683815937167,0.156352707551765,0,0,17.998191681736,51.1325196452123,CCL2
Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),2/98,0.0586971958583037,0.156352707551765,0,0,5.29487179487179,15.0128852925489,EIF2AK2;IGF2BP3
MAPK Cascade (GO:0000165),2/98,0.0586971958583037,0.156352707551765,0,0,5.29487179487179,15.0128852925489,IL31RA;CCL2
Antimicrobial Humoral Response (GO:0019730),2/100,0.0608217071927091,0.157835069923566,0,0,5.18628990057561,14.520618689889,CXCL10;CXCL9
DNA Repair-Dependent Chromatin Remodeling (GO:0140861),1/16,0.0621377268635967,0.157835069923566,0,0,16.7974683544304,46.670118941451,DTX3L
Positive Regulation Of Lymphocyte Migration (GO:2000403),1/16,0.0621377268635967,0.157835069923566,0,0,16.7974683544304,46.670118941451,CXCL10
Positive Regulation Of Myeloid Leukocyte Cytokine Production Involved In Immune Response (GO:0061081),1/16,0.0621377268635967,0.157835069923566,0,0,16.7974683544304,46.670118941451,RIGI
Negative Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046426),1/16,0.0621377268635967,0.157835069923566,0,0,16.7974683544304,46.670118941451,PARP14
Regulation Of Osteoblast Proliferation (GO:0033688),1/16,0.0621377268635967,0.157835069923566,0,0,16.7974683544304,46.670118941451,EIF2AK2
Regulation Of Secretion (GO:0051046),1/16,0.0621377268635967,0.157835069923566,0,0,16.7974683544304,46.670118941451,OAS2
Regulation Of Stem Cell Proliferation (GO:0072091),1/16,0.0621377268635967,0.157835069923566,0,0,16.7974683544304,46.670118941451,EIF2AK2
Regulation Of NMDA Receptor Activity (GO:2000310),1/16,0.0621377268635967,0.157835069923566,0,0,16.7974683544304,46.670118941451,CCL2
Negative Regulation Of ATP-dependent Activity (GO:0032780),1/16,0.0621377268635967,0.157835069923566,0,0,16.7974683544304,46.670118941451,IFIT1
Negative Regulation Of Chemokine Production (GO:0032682),1/16,0.0621377268635967,0.157835069923566,0,0,16.7974683544304,46.670118941451,OAS3
Regulation Of Protein Secretion (GO:0050708),2/102,0.0629723970464633,0.158781545125515,0,0,5.08205128205128,14.0521705723386,RSAD2;CD2AP
Cellular Response To Lipid (GO:0071396),3/228,0.0634352627036798,0.158781545125515,0,0,3.41038961038961,9.4049520816529,CXCL10;CXCL9;CCL2
Negative Regulation Of Cellular Process (GO:0048523),5/537,0.0639948542074107,0.158781545125515,0,0,2.42957393483709,6.67878358959179,IFITM1;EIF2AK2;ADARB1;IFIT3;PML
DNA Damage Response, Signal Transduction By P53 Class Mediator Resulting In Cell Cycle Arrest (GO:0006977),1/17,0.065892171598614,0.158781545125515,0,0,15.746835443038,42.827229519056,PML
Negative Regulation Of Leukocyte Activation (GO:0002695),1/17,0.065892171598614,0.158781545125515,0,0,15.746835443038,42.827229519056,IL31RA
NAD Biosynthetic Process (GO:0009435),1/17,0.065892171598614,0.158781545125515,0,0,15.746835443038,42.827229519056,PARP9
Regulation Of Hematopoietic Progenitor Cell Differentiation (GO:1901532),1/17,0.065892171598614,0.158781545125515,0,0,15.746835443038,42.827229519056,EIF2AK2
T Cell Migration (GO:0072678),1/17,0.065892171598614,0.158781545125515,0,0,15.746835443038,42.827229519056,CXCL10
Negative Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051444),1/17,0.065892171598614,0.158781545125515,0,0,15.746835443038,42.827229519056,DTX3L
Base Conversion Or Substitution Editing (GO:0016553),1/17,0.065892171598614,0.158781545125515,0,0,15.746835443038,42.827229519056,ADARB1
Peptidyl-Threonine Dephosphorylation (GO:0035970),1/17,0.065892171598614,0.158781545125515,0,0,15.746835443038,42.827229519056,PPM1K
Negative Regulation Of Rho Protein Signal Transduction (GO:0035024),1/17,0.065892171598614,0.158781545125515,0,0,15.746835443038,42.827229519056,HEG1
Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),3/232,0.0661090184196065,0.158781545125515,0,0,3.35013894402541,9.10048528770612,STAT1;TRIM22;BIRC3
Negative Regulation Of Programmed Cell Death (GO:0043069),4/381,0.0664794813186337,0.158781545125515,0,0,2.72832612034064,7.39611541370658,IL31RA;CD38;IFIT3;BIRC3
Negative Regulation Of Translation (GO:0017148),2/107,0.0684601163901303,0.158781545125515,0,0,4.83882783882784,12.9753359426836,EIF2AK2;IGF2BP3
Regulation Of Defense Response To Virus (GO:0050688),1/18,0.0696317739420862,0.158781545125515,0,0,14.8198064035741,39.4878823877236,HERC5
Positive Regulation Of Monocyte Chemotaxis (GO:0090026),1/18,0.0696317739420862,0.158781545125515,0,0,14.8198064035741,39.4878823877236,CXCL10
Positive Regulation Of Neuroblast Proliferation (GO:0002052),1/18,0.0696317739420862,0.158781545125515,0,0,14.8198064035741,39.4878823877236,HAPLN3
Vesicle-Mediated Transport In Synapse (GO:0099003),1/18,0.0696317739420862,0.158781545125515,0,0,14.8198064035741,39.4878823877236,OTOF
Positive Regulation Of Stress-Activated Protein Kinase Signaling Cascade (GO:0070304),1/18,0.0696317739420862,0.158781545125515,0,0,14.8198064035741,39.4878823877236,EIF2AK2
Maintenance Of Protein Localization In Organelle (GO:0072595),1/18,0.0696317739420862,0.158781545125515,0,0,14.8198064035741,39.4878823877236,PML
Maintenance Of Protein Location In Nucleus (GO:0051457),1/18,0.0696317739420862,0.158781545125515,0,0,14.8198064035741,39.4878823877236,PML
Regulation Of Vascular Endothelial Cell Proliferation (GO:1905562),1/18,0.0696317739420862,0.158781545125515,0,0,14.8198064035741,39.4878823877236,CCL2
Positive Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900227),1/18,0.0696317739420862,0.158781545125515,0,0,14.8198064035741,39.4878823877236,GBP5
Regulation Of DNA Damage Checkpoint (GO:2000001),1/18,0.0696317739420862,0.158781545125515,0,0,14.8198064035741,39.4878823877236,BRCA2
Response To Organophosphorus (GO:0046683),1/18,0.0696317739420862,0.158781545125515,0,0,14.8198064035741,39.4878823877236,STAT1
Positive Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900017),1/18,0.0696317739420862,0.158781545125515,0,0,14.8198064035741,39.4878823877236,GBP5
Adenylate Cyclase-Activating G Protein-Coupled Receptor Signaling Pathway (GO:0007189),2/110,0.0718262148588771,0.163167476773751,0,0,4.7037037037037,12.3872307975501,CXCL10;CXCL9
Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage By P53 Class Mediator (GO:0042771),1/19,0.0733565917964349,0.16601754985509,0,0,13.9957805907173,36.5628978686321,PML
Regulation Of Interleukin-6 Production (GO:0032675),2/114,0.0763964372400727,0.168705974820883,0,0,4.53479853479853,11.6626820164758,IFIH1;RIGI
Negative Regulation Of Small GTPase Mediated Signal Transduction (GO:0051058),1/20,0.0770666828500711,0.168705974820883,0,0,13.2584943371086,33.9826376278017,CD2AP
Regulation Of Necroptotic Process (GO:0060544),1/20,0.0770666828500711,0.168705974820883,0,0,13.2584943371086,33.9826376278017,BIRC3
Nuclear-Transcribed mRNA poly(A) Tail Shortening (GO:0000289),1/20,0.0770666828500711,0.168705974820883,0,0,13.2584943371086,33.9826376278017,SAMD4A
Lipopolysaccharide-Mediated Signaling Pathway (GO:0031663),1/20,0.0770666828500711,0.168705974820883,0,0,13.2584943371086,33.9826376278017,CCL2
Regulation Of Toll-Like Receptor Signaling Pathway (GO:0034121),1/20,0.0770666828500711,0.168705974820883,0,0,13.2584943371086,33.9826376278017,BIRC3
Regulation Of Calcium Ion Import (GO:0090279),1/20,0.0770666828500711,0.168705974820883,0,0,13.2584943371086,33.9826376278017,CCL2
Sensory Perception Of Pain (GO:0019233),1/20,0.0770666828500711,0.168705974820883,0,0,13.2584943371086,33.9826376278017,CCL2
Endoplasmic Reticulum Calcium Ion Homeostasis (GO:0032469),1/20,0.0770666828500711,0.168705974820883,0,0,13.2584943371086,33.9826376278017,PML
Regulation Of DNA-templated Transcription (GO:0006355),12/1922,0.079675825063914,0.173020594142985,0,0,1.66399753618725,4.20956276851239,ETV7;BATF2;DTX3L;STAT1;SP140;IL31RA;CD38;NCOA7;BRCA2;PARP9;TRIM22;PML
Regulation Of Neurotransmitter Transport (GO:0051588),1/21,0.0807621045750477,0.173020594142985,0,0,12.5949367088608,31.69197707752,OTOF
Macrophage Differentiation (GO:0030225),1/21,0.0807621045750477,0.173020594142985,0,0,12.5949367088608,31.69197707752,IL31RA
Modulation By Host Of Viral Genome Replication (GO:0044827),1/21,0.0807621045750477,0.173020594142985,0,0,12.5949367088608,31.69197707752,IFI27
Modulation By Symbiont Of Entry Into Host (GO:0052372),1/21,0.0807621045750477,0.173020594142985,0,0,12.5949367088608,31.69197707752,TRIM22
Positive Regulation Of T Cell Cytokine Production (GO:0002726),1/21,0.0807621045750477,0.173020594142985,0,0,12.5949367088608,31.69197707752,RSAD2
Positive Regulation Of Synaptic Transmission, Glutamatergic (GO:0051968),1/22,0.0844429142331598,0.177743476812455,0,0,11.994575045208,29.646745779716,CCL2
Regulation Of Protein Export From Nucleus (GO:0046825),1/22,0.0844429142331598,0.177743476812455,0,0,11.994575045208,29.646745779716,IFI27
Cellular Response To Interferon-Beta (GO:0035458),1/22,0.0844429142331598,0.177743476812455,0,0,11.994575045208,29.646745779716,STAT1
Modulation By Host Of Viral Process (GO:0044788),1/22,0.0844429142331598,0.177743476812455,0,0,11.994575045208,29.646745779716,IFI27
Dendritic Cell Differentiation (GO:0097028),1/22,0.0844429142331598,0.177743476812455,0,0,11.994575045208,29.646745779716,BATF2
Positive Regulation Of Macromolecule Biosynthetic Process (GO:0010557),2/122,0.0858033067974172,0.179977667916534,0,0,4.23076923076923,10.3894904065973,SAMD4A;CCL2
Regulation Of Cell Motility (GO:2000145),2/123,0.0870029524238828,0.18123217204671,0,0,4.19559228650138,10.2448527318731,NEXN;RIGI
Protein Localization To Cell Junction (GO:1902414),1/23,0.0881091688442001,0.18123217204671,0,0,11.4487917146145,27.8111607255401,HEG1
Regulation Of T Cell Migration (GO:2000404),1/23,0.0881091688442001,0.18123217204671,0,0,11.4487917146145,27.8111607255401,CXCL10
Positive Regulation Of Epithelial Cell Apoptotic Process (GO:1904037),1/23,0.0881091688442001,0.18123217204671,0,0,11.4487917146145,27.8111607255401,CCL2
Entrainment Of Circadian Clock By Photoperiod (GO:0043153),1/23,0.0881091688442001,0.18123217204671,0,0,11.4487917146145,27.8111607255401,PML
Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),2/124,0.0882076850659237,0.18123217204671,0,0,4.16099201345103,10.1031432093516,BLNK;IL31RA
Protein-Containing Complex Organization (GO:0043933),2/126,0.0906321772793038,0.181710779583334,0,0,4.09346567411084,9.8281899192327,PML;CD2AP
Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000116),1/24,0.0917609252380958,0.181710779583334,0,0,10.9504678040726,26.155944898719,BIRC3
Gliogenesis (GO:0042063),1/24,0.0917609252380958,0.181710779583334,0,0,10.9504678040726,26.155944898719,HAPLN3
Regulation Of Neuroblast Proliferation (GO:1902692),1/24,0.0917609252380958,0.181710779583334,0,0,10.9504678040726,26.155944898719,HAPLN3
Protein Kinase B Signaling (GO:0043491),1/24,0.0917609252380958,0.181710779583334,0,0,10.9504678040726,26.155944898719,CCL2
Photoperiodism (GO:0009648),1/24,0.0917609252380958,0.181710779583334,0,0,10.9504678040726,26.155944898719,PML
Mononuclear Cell Differentiation (GO:1903131),1/24,0.0917609252380958,0.181710779583334,0,0,10.9504678040726,26.155944898719,IL31RA
Regulation Of Viral Life Cycle (GO:1903900),1/24,0.0917609252380958,0.181710779583334,0,0,10.9504678040726,26.155944898719,TRIM22
Response To Purine-Containing Compound (GO:0014074),1/24,0.0917609252380958,0.181710779583334,0,0,10.9504678040726,26.155944898719,STAT1
Eosinophil Chemotaxis (GO:0048245),1/24,0.0917609252380958,0.181710779583334,0,0,10.9504678040726,26.155944898719,CCL2
Eosinophil Migration (GO:0072677),1/24,0.0917609252380958,0.181710779583334,0,0,10.9504678040726,26.155944898719,CCL2
Negative Regulation Of Protein Transport (GO:0051224),1/25,0.0953982400052787,0.185856765317727,0,0,10.493670886076,24.656927579154,RSAD2
Negative Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903051),1/25,0.0953982400052787,0.185856765317727,0,0,10.493670886076,24.656927579154,PML
Regulation Of Monocyte Chemotaxis (GO:0090025),1/25,0.0953982400052787,0.185856765317727,0,0,10.493670886076,24.656927579154,CXCL10
Positive Regulation Of T Cell Migration (GO:2000406),1/25,0.0953982400052787,0.185856765317727,0,0,10.493670886076,24.656927579154,CXCL10
Response To dsRNA (GO:0043331),1/25,0.0953982400052787,0.185856765317727,0,0,10.493670886076,24.656927579154,RIGI
Regulation Of Cell Migration (GO:0030334),4/434,0.0961093564554479,0.186638169632838,0,0,2.38555691554468,5.58761507131174,IFITM1;NEXN;ADARB1;RIGI
Mitotic G1 DNA Damage Checkpoint Signaling (GO:0031571),1/26,0.0990211695219052,0.19092755708549,0,0,10.073417721519,23.2939889079168,PML
Positive Regulation Of Erythrocyte Differentiation (GO:0045648),1/26,0.0990211695219052,0.19092755708549,0,0,10.073417721519,23.2939889079168,STAT1
Negative Regulation Of Cell Motility (GO:2000146),2/133,0.0992696434680371,0.19092755708549,0,0,3.87336073595616,8.94713584585087,IFITM1;ADARB1
Antigen Receptor-Mediated Signaling Pathway (GO:0050851),2/134,0.100522082884844,0.192720681199605,0,0,3.84382284382284,8.83071344312827,BLNK;CD38
Positive Regulation Of Immune System Process (GO:0002684),1/27,0.102629769964322,0.194899436966945,0,0,9.68549172346641,22.050254220071,RSAD2
GPI Anchor Metabolic Process (GO:0006505),1/27,0.102629769964322,0.194899436966945,0,0,9.68549172346641,22.050254220071,PGAP1
Clathrin-Dependent Endocytosis (GO:0072583),1/27,0.102629769964322,0.194899436966945,0,0,9.68549172346641,22.050254220071,SIGLEC1
Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),2/137,0.104305957615707,0.19745970592659,0,0,3.75783475783476,8.49431039135594,EIF2AK2;IGF2BP3
Protein Localization To Golgi Apparatus (GO:0034067),1/28,0.106224097275717,0.199211546915831,0,0,9.32630098452883,20.9114720889577,GBP5
Membrane Fusion (GO:0061025),1/28,0.106224097275717,0.199211546915831,0,0,9.32630098452883,20.9114720889577,OTOF
Pyroptosis (GO:0070269),1/28,0.106224097275717,0.199211546915831,0,0,9.32630098452883,20.9114720889577,IFI27
Positive Regulation Of Neural Precursor Cell Proliferation (GO:2000179),1/29,0.109804207201114,0.203391177646371,0,0,8.99276672694394,19.8655291948356,HAPLN3
Lipid Droplet Organization (GO:0034389),1/29,0.109804207201114,0.203391177646371,0,0,8.99276672694394,19.8655291948356,RNF213
Positive Regulation Of B Cell Proliferation (GO:0030890),1/29,0.109804207201114,0.203391177646371,0,0,8.99276672694394,19.8655291948356,CD38
Positive Regulation Of Calcium Ion Transport (GO:0051928),1/29,0.109804207201114,0.203391177646371,0,0,8.99276672694394,19.8655291948356,CCL2
DNA Repair (GO:0006281),3/291,0.111134930881275,0.205224626964809,0,0,2.65584415584416,5.83491675943888,DTX3L;BRCA2;PARP9
Actin Filament Organization (GO:0007015),2/144,0.113283017726491,0.207443262810391,0,0,3.5713253882268,7.77786817315798,NEBL;CD2AP
GPI Anchor Biosynthetic Process (GO:0006506),1/30,0.113370155256841,0.207443262810391,0,0,8.68223483195111,18.9020683044028,PGAP1
Negative Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050732),1/30,0.113370155256841,0.207443262810391,0,0,8.68223483195111,18.9020683044028,PARP14
Positive Regulation Of Cellular Catabolic Process (GO:0031331),2/146,0.115884060977505,0.210592814176139,0,0,3.52136752136752,7.58912825256618,DTX3L;TRIM22
Positive Regulation Of Mononuclear Cell Migration (GO:0071677),1/31,0.116921996719506,0.210592814176139,0,0,8.39240506329114,18.0121847746198,CXCL10
Regulation Of Macrophage Activation (GO:0043030),1/31,0.116921996719506,0.210592814176139,0,0,8.39240506329114,18.0121847746198,IL31RA
Positive Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001238),1/31,0.116921996719506,0.210592814176139,0,0,8.39240506329114,18.0121847746198,PML
Regulation Of Cell Cycle (GO:0051726),3/298,0.117108093224936,0.210592814176139,0,0,2.59189962579793,5.55873800063571,MX2;ADARB1;BIRC3
Negative Regulation Of Protein Metabolic Process (GO:0051248),2/147,0.117190353403665,0.210592814176139,0,0,3.49690539345712,7.4972102998619,EIF2AK2;IGF2BP3
NIK/NF-kappaB Signaling (GO:0038061),1/32,0.120459786733955,0.214546720751008,0,0,8.12127398938342,17.1881834518052,BIRC3
Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051438),1/32,0.120459786733955,0.214546720751008,0,0,8.12127398938342,17.1881834518052,DTX3L
Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134),1/32,0.120459786733955,0.214546720751008,0,0,8.12127398938342,17.1881834518052,CCL2
Positive Regulation Of Ion Transmembrane Transporter Activity (GO:0032414),1/33,0.123983580155764,0.21888010338349,0,0,7.86708860759494,16.4233824830575,CCL2
Glycolipid Metabolic Process (GO:0006664),1/33,0.123983580155764,0.21888010338349,0,0,7.86708860759494,16.4233824830575,PGAP1
Positive Regulation Of Chromosome Organization (GO:2001252),1/33,0.123983580155764,0.21888010338349,0,0,7.86708860759494,16.4233824830575,PML
Glial Cell Differentiation (GO:0010001),1/34,0.127493431661207,0.222466799594338,0,0,7.6283084004603,15.7119538254855,HAPLN3
Apoptotic Mitochondrial Changes (GO:0008637),1/34,0.127493431661207,0.222466799594338,0,0,7.6283084004603,15.7119538254855,IFIT2
Purine Nucleotide Metabolic Process (GO:0006163),1/34,0.127493431661207,0.222466799594338,0,0,7.6283084004603,15.7119538254855,CD38
Negative Regulation Of Ras Protein Signal Transduction (GO:0046580),1/34,0.127493431661207,0.222466799594338,0,0,7.6283084004603,15.7119538254855,HEG1
Intrinsic Apoptotic Signaling Pathway By P53 Class Mediator (GO:0072332),1/35,0.13098939570705,0.227249614454306,0,0,7.40357408786299,15.0487927482045,PML
Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807),1/35,0.13098939570705,0.227249614454306,0,0,7.40357408786299,15.0487927482045,CCL2
DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0030330),1/36,0.134471526562548,0.229976872132539,0,0,7.19168173598553,14.4294103773367,PML
Regulation Of Erythrocyte Differentiation (GO:0045646),1/36,0.134471526562548,0.229976872132539,0,0,7.19168173598553,14.4294103773367,STAT1
Positive Regulation Of Myeloid Cell Differentiation (GO:0045639),1/36,0.134471526562548,0.229976872132539,0,0,7.19168173598553,14.4294103773367,STAT1
Regulation Of Intracellular Protein Transport (GO:0033157),1/36,0.134471526562548,0.229976872132539,0,0,7.19168173598553,14.4294103773367,IFI27
Positive Regulation Of Signaling Receptor Activity (GO:2000273),1/36,0.134471526562548,0.229976872132539,0,0,7.19168173598553,14.4294103773367,CCL2
Positive Regulation Of Immune Effector Process (GO:0002699),1/37,0.137939878234653,0.233204087051602,0,0,6.9915611814346,13.8498447051279,DDX60
Synaptic Vesicle Cycle (GO:0099504),1/37,0.137939878234653,0.233204087051602,0,0,6.9915611814346,13.8498447051279,OTOF
Negative Regulation Of Transferase Activity (GO:0051348),1/37,0.137939878234653,0.233204087051602,0,0,6.9915611814346,13.8498447051279,DTX3L
Adenylate Cyclase-Modulating G Protein-Coupled Receptor Signaling Pathway (GO:0007188),2/163,0.138571778071225,0.233204087051602,0,0,3.1468386685778,6.2193075777208,CXCL10;CXCL9
Negative Regulation Of Cell Migration (GO:0030336),2/163,0.138571778071225,0.233204087051602,0,0,3.1468386685778,6.2193075777208,IFITM1;ADARB1
Regulation Of Intracellular Transport (GO:0032386),1/38,0.141394504607699,0.233204087051602,0,0,6.80225795415669,13.3065864680218,MX2
Negative Regulation Of Type I Interferon Production (GO:0032480),1/38,0.141394504607699,0.233204087051602,0,0,6.80225795415669,13.3065864680218,XAF1
Regulation Of Neurotransmitter Secretion (GO:0046928),1/38,0.141394504607699,0.233204087051602,0,0,6.80225795415669,13.3065864680218,OTOF
Maturation Of SSU-rRNA (GO:0030490),1/38,0.141394504607699,0.233204087051602,0,0,6.80225795415669,13.3065864680218,IGF2BP3
Regulation Of Telomere Maintenance (GO:0032204),1/38,0.141394504607699,0.233204087051602,0,0,6.80225795415669,13.3065864680218,PML
Response To cAMP (GO:0051591),1/38,0.141394504607699,0.233204087051602,0,0,6.80225795415669,13.3065864680218,STAT1
Response To Peptide (GO:1901652),1/38,0.141394504607699,0.233204087051602,0,0,6.80225795415669,13.3065864680218,STAT1
Signal Release From Synapse (GO:0099643),1/38,0.141394504607699,0.233204087051602,0,0,6.80225795415669,13.3065864680218,OTOF
Positive Regulation Of Intracellular Transport (GO:0032388),1/39,0.144835459249559,0.236289827827194,0,0,6.62291805463025,12.7965171133642,PGAP1
Negative Regulation Of Protein Secretion (GO:0050709),1/39,0.144835459249559,0.236289827827194,0,0,6.62291805463025,12.7965171133642,RSAD2
Negative Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000059),1/39,0.144835459249559,0.236289827827194,0,0,6.62291805463025,12.7965171133642,PML
Nuclear-Transcribed mRNA Catabolic Process, Deadenylation-Dependent Decay (GO:0000288),1/39,0.144835459249559,0.236289827827194,0,0,6.62291805463025,12.7965171133642,SAMD4A
Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991),1/40,0.148262795639544,0.239930653158617,0,0,6.45277507302824,12.3168565949109,CCL2
Negative Regulation Of Secretion By Cell (GO:1903531),1/40,0.148262795639544,0.239930653158617,0,0,6.45277507302824,12.3168565949109,RSAD2
Endothelial Cell Migration (GO:0043542),1/40,0.148262795639544,0.239930653158617,0,0,6.45277507302824,12.3168565949109,STAT1
Regulation Of Chemokine Production (GO:0032642),1/41,0.1516765669633,0.24219971700771,0,0,6.29113924050633,11.8651192715426,EIF2AK2
Synaptic Vesicle Exocytosis (GO:0016079),1/41,0.1516765669633,0.24219971700771,0,0,6.29113924050633,11.8651192715426,OTOF
Positive Regulation Of Response To Biotic Stimulus (GO:0002833),1/41,0.1516765669633,0.24219971700771,0,0,6.29113924050633,11.8651192715426,GBP5
Lymphocyte Migration (GO:0072676),1/41,0.1516765669633,0.24219971700771,0,0,6.29113924050633,11.8651192715426,CCL2
Response To Amino Acid Starvation (GO:1990928),1/41,0.1516765669633,0.24219971700771,0,0,6.29113924050633,11.8651192715426,EIF2AK2
Cellular Response To Amino Acid Starvation (GO:0034198),1/42,0.155076826221061,0.244465018201859,0,0,6.13738808274159,11.4390764575281,EIF2AK2
Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000058),1/42,0.155076826221061,0.244465018201859,0,0,6.13738808274159,11.4390764575281,PML
Monocyte Chemotaxis (GO:0002548),1/42,0.155076826221061,0.244465018201859,0,0,6.13738808274159,11.4390764575281,CCL2
Negative Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043124),1/42,0.155076826221061,0.244465018201859,0,0,6.13738808274159,11.4390764575281,STAT1
Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),2/175,0.155125642779253,0.244465018201859,0,0,2.92678227360308,5.45411698595768,TRIM22;BIRC3
Positive Regulation Of Hydrolase Activity (GO:0051345),2/176,0.156522367426451,0.246022102325648,0,0,2.90981432360743,5.3964146496785,CCL2;AGRN
Regulation Of Endothelial Cell Apoptotic Process (GO:2000351),1/43,0.158463626233836,0.246498974141523,0,0,5.99095840867993,11.0367245043274,CCL2
Regulation Of Filopodium Assembly (GO:0051489),1/43,0.158463626233836,0.246498974141523,0,0,5.99095840867993,11.0367245043274,AGRN
Neurotransmitter Secretion (GO:0007269),1/43,0.158463626233836,0.246498974141523,0,0,5.99095840867993,11.0367245043274,OTOF
Regulation Of Primary Metabolic Process (GO:0080090),1/43,0.158463626233836,0.246498974141523,0,0,5.99095840867993,11.0367245043274,RNF213
Positive Regulation Of Leukocyte Cell-Cell Adhesion (GO:1903039),1/44,0.161837019617648,0.249809963614934,0,0,5.85133941713276,10.6562574864039,CCL2
Positive Regulation Of Osteoblast Differentiation (GO:0045669),1/44,0.161837019617648,0.249809963614934,0,0,5.85133941713276,10.6562574864039,IFITM1
Regulation Of B Cell Proliferation (GO:0030888),1/44,0.161837019617648,0.249809963614934,0,0,5.85133941713276,10.6562574864039,CD38
Regulation Of Gene Expression (GO:0010468),7/1127,0.163918907101712,0.252376424744835,0,0,1.60958904109589,2.91075417088972,IGF2BP3;BRCA2;PARP9;PARP14;TRIM22;PML;RIGI
Positive Regulation Of Innate Immune Response (GO:0045089),1/45,0.165197058719789,0.252407688703839,0,0,5.7180667433832,10.2960437389783,GBP5
I-kappaB kinase/NF-kappaB Signaling (GO:0007249),1/45,0.165197058719789,0.252407688703839,0,0,5.7180667433832,10.2960437389783,BIRC3
Regulation Of Stem Cell Differentiation (GO:2000736),1/45,0.165197058719789,0.252407688703839,0,0,5.7180667433832,10.2960437389783,EIF2AK2
Epithelial Cell Migration (GO:0010631),1/46,0.168543795797644,0.255575226877032,0,0,5.59071729957806,9.95460562280523,STAT1
Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900015),1/46,0.168543795797644,0.255575226877032,0,0,5.59071729957806,9.95460562280523,GBP5
Replication Fork Processing (GO:0031297),1/46,0.168543795797644,0.255575226877032,0,0,5.59071729957806,9.95460562280523,BRCA2
Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),2/186,0.170617892525097,0.258070279648514,0,0,2.75027870680045,4.86339696121648,PARP9;PARP14
Positive Regulation Of Lymphocyte Activation (GO:0051251),1/47,0.171877282811721,0.258675310631641,0,0,5.46890478811227,9.63060203249414,CCL2
Positive Regulation Of Smooth Muscle Cell Proliferation (GO:0048661),1/47,0.171877282811721,0.258675310631641,0,0,5.46890478811227,9.63060203249414,STAT1
Cellular Response To Radiation (GO:0071478),1/48,0.175197571563056,0.263014808181945,0,0,5.35227578777269,9.32281320448011,BRCA2
Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:0008630),1/49,0.178504713661488,0.26731302891596,0,0,5.24050632911392,9.03012749635686,PML
G Protein-Coupled Receptor Signaling Pathway, Coupled To Cyclic Nucleotide Second Messenger (GO:0007187),1/50,0.181798760490535,0.270898153008173,0,0,5.13329888917592,8.75152984263767,CCL2
Positive Regulation Of Developmental Growth (GO:0048639),1/50,0.181798760490535,0.270898153008173,0,0,5.13329888917592,8.75152984263767,AGRN
Positive Regulation Of Protein Metabolic Process (GO:0051247),2/196,0.184919107630942,0.272415690616626,0,0,2.60719006079831,4.40051134375012,SAMD4A;RIGI
RNA Modification (GO:0009451),1/51,0.185079763226246,0.272415690616626,0,0,5.03037974683544,8.48609164398205,ADARB1
Regulation Of Stress-Activated MAPK Cascade (GO:0032872),1/51,0.185079763226246,0.272415690616626,0,0,5.03037974683544,8.48609164398205,EIF2AK2
Regulated Exocytosis (GO:0045055),1/51,0.185079763226246,0.272415690616626,0,0,5.03037974683544,8.48609164398205,OTOF
Sensory Perception (GO:0007600),1/51,0.185079763226246,0.272415690616626,0,0,5.03037974683544,8.48609164398205,CCL2
Sprouting Angiogenesis (GO:0002040),1/52,0.188347772887413,0.274540821496908,0,0,4.93149664929263,8.23296188823832,RNF213
Positive Regulation Of Telomere Maintenance (GO:0032206),1/52,0.188347772887413,0.274540821496908,0,0,4.93149664929263,8.23296188823832,PML
Cellular Response To Ionizing Radiation (GO:0071479),1/52,0.188347772887413,0.274540821496908,0,0,4.93149664929263,8.23296188823832,BRCA2
Positive Regulation Of B Cell Activation (GO:0050871),1/52,0.188347772887413,0.274540821496908,0,0,4.93149664929263,8.23296188823832,CD38
Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904029),1/53,0.191602840296384,0.276606498461447,0,0,4.83641674780915,7.99135933578843,HERC5
mRNA Stabilization (GO:0048255),1/53,0.191602840296384,0.276606498461447,0,0,4.83641674780915,7.99135933578843,IGF2BP3
Protein Homotetramerization (GO:0051289),1/53,0.191602840296384,0.276606498461447,0,0,4.83641674780915,7.99135933578843,GBP5
Positive Regulation Of NIK/NF-kappaB Signaling (GO:1901224),1/53,0.191602840296384,0.276606498461447,0,0,4.83641674780915,7.99135933578843,EIF2AK2
Positive Regulation Of Leukocyte Chemotaxis (GO:0002690),1/54,0.194845016067921,0.278614488534177,0,0,4.74492476713637,7.76056562137313,CXCL10
Negative Regulation Of Protein Ubiquitination (GO:0031397),1/54,0.194845016067921,0.278614488534177,0,0,4.74492476713637,7.76056562137313,DTX3L
Regulation Of Lipid Metabolic Process (GO:0019216),1/54,0.194845016067921,0.278614488534177,0,0,4.74492476713637,7.76056562137313,RNF213
Regulation Of Smooth Muscle Cell Proliferation (GO:0048660),1/54,0.194845016067921,0.278614488534177,0,0,4.74492476713637,7.76056562137313,STAT1
Regulation Of Synaptic Transmission, Glutamatergic (GO:0051966),1/55,0.198074350586938,0.281893047407415,0,0,4.65682137834037,7.53991915108379,CCL2
Response To Peptide Hormone (GO:0043434),1/55,0.198074350586938,0.281893047407415,0,0,4.65682137834037,7.53991915108379,STAT1
Nucleotide-Excision Repair (GO:0006289),1/56,0.201290894069444,0.285795090164636,0,0,4.57192174913694,7.32880968812737,BRCA2
Positive Regulation Of Interleukin-1 Beta Production (GO:0032731),1/57,0.204494696527193,0.288303998382601,0,0,4.49005424954792,7.12667354281938,GBP5
Post-Transcriptional Regulation Of Gene Expression (GO:0010608),1/57,0.204494696527193,0.288303998382601,0,0,4.49005424954792,7.12667354281938,PARP9
Endosome To Lysosome Transport (GO:0008333),1/57,0.204494696527193,0.288303998382601,0,0,4.49005424954792,7.12667354281938,DTX3L
Renal System Development (GO:0072001),1/58,0.207685807834421,0.290085513494945,0,0,4.41105929380413,6.93298928590376,STAT1
Muscle Organ Development (GO:0007517),1/58,0.207685807834421,0.290085513494945,0,0,4.41105929380413,6.93298928590376,CXCL10
Response To Organic Cyclic Compound (GO:0014070),1/58,0.207685807834421,0.290085513494945,0,0,4.41105929380413,6.93298928590376,CCL2
Selective Autophagy (GO:0061912),1/58,0.207685807834421,0.290085513494945,0,0,4.41105929380413,6.93298928590376,RNF213
Positive Regulation Of Protein Binding (GO:0032092),1/59,0.210864277605035,0.292090749286073,0,0,4.33478830205151,6.74727392632872,DTX3L
Regulation Of Multicellular Organismal Development (GO:2000026),1/59,0.210864277605035,0.292090749286073,0,0,4.33478830205151,6.74727392632872,OAS2
Regulation Of Type I Interferon Production (GO:0032479),1/59,0.210864277605035,0.292090749286073,0,0,4.33478830205151,6.74727392632872,XAF1
Regulation Of GTPase Activity (GO:0043087),2/214,0.211062252391099,0.292090749286073,0,0,2.38364779874214,3.70800765008023,CCL2;AGRN
Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),1/60,0.214030155286213,0.294169300187899,0,0,4.26110276764643,6.56907948819503,PML
Negative Regulation Of Peptidase Activity (GO:0010466),1/60,0.214030155286213,0.294169300187899,0,0,4.26110276764643,6.56907948819503,SERPING1
Homophilic Cell Adhesion Via Plasma Membrane Adhesion Molecules (GO:0007156),1/60,0.214030155286213,0.294169300187899,0,0,4.26110276764643,6.56907948819503,NEXN
Positive Regulation Of Interleukin-8 Production (GO:0032757),1/61,0.217183490122814,0.297823373699166,0,0,4.18987341772152,6.39798994596785,RIGI
Proteasomal Protein Catabolic Process (GO:0010498),2/220,0.219863441031942,0.30007974521704,0,0,2.31733709715361,3.51018323473435,IFI27;PML
Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),1/62,0.220324331205867,0.30007974521704,0,0,4.12097945631874,6.23361847131107,PML
Regulation Of T Cell Activation (GO:0050863),1/62,0.220324331205867,0.30007974521704,0,0,4.12097945631874,6.23361847131107,CCL2
Cellular Response To Oxygen-Containing Compound (GO:1901701),3/406,0.221634234354103,0.301182413275779,0,0,1.88685508040347,2.84297520959598,CXCL10;CXCL9;CCL2
Phosphatidylinositol Metabolic Process (GO:0046488),1/63,0.223452727406194,0.302969688960651,0,0,4.05430788076766,6.07560495901409,PGAP1
Negative Regulation Of DNA-templated Transcription (GO:0045892),6/1025,0.226499821606394,0.30513282752101,0,0,1.50393867861974,2.23336566405864,ETV7;IFI27;STAT1;CD38;PARP9;PML
Positive Regulation Of Interleukin-1 Production (GO:0032732),1/64,0.22656872741178,0.30513282752101,0,0,3.98975286317058,5.92361379596917,GBP5
Regulation Of Secretion By Cell (GO:1903530),1/64,0.22656872741178,0.30513282752101,0,0,3.98975286317058,5.92361379596917,OTOF
Apoptotic Process (GO:0006915),2/228,0.231647046874976,0.311275719238249,0,0,2.23439981847062,3.26790003872069,IFI27;IFIT2
Negative Regulation Of Endopeptidase Activity (GO:0010951),1/66,0.232763732588196,0.312079659283061,0,0,3.8666017526777,5.63646664354379,SERPING1
Extrinsic Apoptotic Signaling Pathway (GO:0097191),1/67,0.23584283421526,0.315118944346016,0,0,3.8078250863061,5.50074471828083,IFI27
Negative Regulation Of Intracellular Signal Transduction (GO:1902532),2/231,0.23607748156155,0.315118944346016,0,0,2.20479229649535,3.18282761179759,STAT1;CD2AP
B Cell Differentiation (GO:0030183),1/68,0.238909732525108,0.318193935796714,0,0,3.75080294728887,5.36991012977869,BLNK
Positive Regulation Of GTPase Activity (GO:0043547),2/234,0.24051303810596,0.31962218309004,0,0,2.17595048629531,3.10068805292622,CCL2;AGRN
Positive Regulation Of Protein Transport (GO:0051222),1/70,0.245007109989304,0.324877269192865,0,0,3.64171711612548,5.12195876548416,CD2AP
Regulation Of Inflammatory Response (GO:0050727),2/240,0.249396554943182,0.32997082654021,0,0,2.12044817927171,2.94468983703843,USP18;BIRC3
Regulation Of Cellular Localization (GO:0060341),1/72,0.251056244821686,0.329990959350775,0,0,3.53877696559101,4.89086678897906,TRIM22
Response To Ionizing Radiation (GO:0010212),1/72,0.251056244821686,0.329990959350775,0,0,3.53877696559101,4.89086678897906,BRCA2
Negative Regulation Of Catabolic Process (GO:0009895),1/72,0.251056244821686,0.329990959350775,0,0,3.53877696559101,4.89086678897906,PML
Positive Regulation Of Secretion By Cell (GO:1903532),1/73,0.254062839181868,0.331769694549858,0,0,3.48945147679325,4.7811544462438,CD2AP
Protein Tetramerization (GO:0051262),1/73,0.254062839181868,0.331769694549858,0,0,3.48945147679325,4.7811544462438,GBP5
Regulation Of Rho Protein Signal Transduction (GO:0035023),1/73,0.254062839181868,0.331769694549858,0,0,3.48945147679325,4.7811544462438,HEG1
Positive Regulation Of Programmed Cell Death (GO:0043068),2/245,0.256808710471783,0.333509964233987,0,0,2.07628996517885,2.8225579704027,GBP5;IFIT2
Positive Regulation Of Lymphocyte Proliferation (GO:0050671),1/74,0.25705751396108,0.333509964233987,0,0,3.44147737125022,4.67509362010551,CD38
Negative Regulation Of Neuron Apoptotic Process (GO:0043524),1/74,0.25705751396108,0.333509964233987,0,0,3.44147737125022,4.67509362010551,CCL2
Positive Regulation Of Neurogenesis (GO:0050769),1/75,0.260040315844136,0.33665434438316,0,0,3.39479986315429,4.57251907572925,HAPLN3
Positive Regulation Of Protein Secretion (GO:0050714),1/76,0.263011291333037,0.339769951464567,0,0,3.3493670886076,4.4732750648447,CD2AP
Actomyosin Structure Organization (GO:0031032),1/77,0.26597048667499,0.342124429440906,0,0,3.30512991339107,4.37721466776103,FRMD3
Positive Regulation Of Synaptic Transmission (GO:0050806),1/77,0.26597048667499,0.342124429440906,0,0,3.30512991339107,4.37721466776103,CCL2
Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),3/452,0.270799912093215,0.346728687021628,0,0,1.68955543343071,2.20719308505157,BRCA2;TRIM22;PML
Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079),1/79,0.271853721385729,0.346728687021628,0,0,3.22005842259007,4.19409758621636,HERC5
Vesicle Fusion (GO:0006906),1/79,0.271853721385729,0.346728687021628,0,0,3.22005842259007,4.19409758621636,SAMD9
Positive Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903322),1/79,0.271853721385729,0.346728687021628,0,0,3.22005842259007,4.19409758621636,BIRC3
Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901),1/80,0.274777852453819,0.349717266759406,0,0,3.17913795866047,4.10678598977008,HEG1
Regulation Of Interleukin-8 Production (GO:0032677),1/81,0.277690386752126,0.351936026999537,0,0,3.13924050632911,4.02214719820431,RIGI
Cellular Response To Interleukin-1 (GO:0071347),1/81,0.277690386752126,0.351936026999537,0,0,3.13924050632911,4.02214719820431,CCL2
Cellular Component Assembly (GO:0022607),2/260,0.279062815549586,0.352932384371536,0,0,1.95408467501491,2.49403418125443,PML;CD2AP
Cellular Response To Organic Substance (GO:0071310),1/82,0.280591369806463,0.354121602984258,0,0,3.10032817627754,3.94007025554917,CCL2
Positive Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032436),1/83,0.283480846786432,0.355532228677983,0,0,3.06236492744674,3.86045004976092,RNF144A
Positive Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000060),1/83,0.283480846786432,0.355532228677983,0,0,3.06236492744674,3.86045004976092,RNF144A
Regulation Of NIK/NF-kappaB Signaling (GO:1901222),1/83,0.283480846786432,0.355532228677983,0,0,3.06236492744674,3.86045004976092,EIF2AK2
Regulation Of Interleukin-1 Beta Production (GO:0032651),1/84,0.286358862794009,0.356790427330908,0,0,3.0253164556962,3.78318693721785,GBP5
Positive Regulation Of Protein Ubiquitination (GO:0031398),1/84,0.286358862794009,0.356790427330908,0,0,3.0253164556962,3.78318693721785,BIRC3
Ribosomal Small Subunit Biogenesis (GO:0042274),1/84,0.286358862794009,0.356790427330908,0,0,3.0253164556962,3.78318693721785,IGF2BP3
Regulation Of Osteoblast Differentiation (GO:0045667),1/85,0.289225462686849,0.356790427330908,0,0,2.98915009041591,3.70818640022107,IFITM1
Nuclear-Transcribed mRNA Catabolic Process (GO:0000956),1/85,0.289225462686849,0.356790427330908,0,0,2.98915009041591,3.70818640022107,SAMD4A
Positive Regulation Of Amide Metabolic Process (GO:0034250),1/85,0.289225462686849,0.356790427330908,0,0,2.98915009041591,3.70818640022107,SAMD4A
Response To Interleukin-1 (GO:0070555),1/85,0.289225462686849,0.356790427330908,0,0,2.98915009041591,3.70818640022107,CCL2
Defense Response To Gram-positive Bacterium (GO:0050830),1/85,0.289225462686849,0.356790427330908,0,0,2.98915009041591,3.70818640022107,GBP4
Regulation Of Transcription By RNA Polymerase II (GO:0006357),10/2028,0.290851423909638,0.35806248914847,0,0,1.2673085091321,1.56505340841669,ETV7;BATF2;CXCL10;IFI27;STAT1;SP140;NCOA7;PARP9;AGRN;RIGI
Regulation Of Double-Strand Break Repair (GO:2000779),1/88,0.297757211938595,0.363589942367209,0,0,2.88563945875164,3.49588540052321,PML
Negative Regulation Of Neuron Death (GO:1901215),1/88,0.297757211938595,0.363589942367209,0,0,2.88563945875164,3.49588540052321,CCL2
Negative Regulation Of Protein Kinase Activity (GO:0006469),1/88,0.297757211938595,0.363589942367209,0,0,2.88563945875164,3.49588540052321,ADARB1
Positive Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120034),1/88,0.297757211938595,0.363589942367209,0,0,2.88563945875164,3.49588540052321,AGRN
Positive Regulation Of Gene Expression (GO:0010628),3/480,0.301345439106343,0.36722662822271,0,0,1.58809115412889,1.9049122172532,SAMD4A;EIF2AK2;RIGI
Positive Regulation Of Proteasomal Protein Catabolic Process (GO:1901800),1/90,0.303388779350278,0.368969788219934,0,0,2.82050917365951,3.36413466397973,RNF144A
Lymphocyte Differentiation (GO:0030098),1/91,0.306187815508842,0.37087538216564,0,0,2.78902953586498,3.30097428448082,BLNK
rRNA Metabolic Process (GO:0016072),1/91,0.306187815508842,0.37087538216564,0,0,2.78902953586498,3.30097428448082,IGF2BP3
B Cell Activation (GO:0042113),1/92,0.308975744966249,0.373500800139923,0,0,2.75824175824176,3.23953425940067,BLNK
Regulation Of Endothelial Cell Proliferation (GO:0001936),1/93,0.311752611163957,0.376102348538481,0,0,2.72812328013209,3.17975131780462,STAT1
Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),2/284,0.314567718422896,0.378739532981167,0,0,1.78559738134206,2.06514319555859,BLNK;IL31RA
Recombinational Repair (GO:0000725),1/95,0.317273327187397,0.381234616700226,0,0,2.66980877996229,3.06491817511279,BRCA2
Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),5/938,0.321513239873731,0.385559701999972,0,0,1.3566988210075,1.53946861178396,CXCL10;STAT1;NCOA7;AGRN;RIGI
Regulation Of Protein Localization (GO:0032880),1/97,0.322750308395188,0.386273728934201,0,0,2.61392405063291,2.95602474247775,TRIM22
Positive Regulation Of Protein-Containing Complex Assembly (GO:0031334),1/98,0.325472505417683,0.388758825915566,0,0,2.58684588281352,2.9036757553192,GBP5
Regulation Of Organelle Organization (GO:0033043),1/100,0.330884524972772,0.393661035639543,0,0,2.5343306482547,2.80293378962301,NEXN
ncRNA Processing (GO:0034470),1/100,0.330884524972772,0.393661035639543,0,0,2.5343306482547,2.80293378962301,IGF2BP3
Gene Expression (GO:0010467),2/296,0.332198258690371,0.394444480732946,0,0,1.71166928309785,1.88629947220793,IGF2BP3;ADARB1
rRNA Processing (GO:0006364),1/101,0.333574431994978,0.395298834765703,0,0,2.50886075949367,2.75445126797071,IGF2BP3
Positive Regulation Of Stress-Activated MAPK Cascade (GO:0032874),1/105,0.344227687389332,0.404736460563238,0,0,2.41187925998053,2.57215336073768,EIF2AK2
Intrinsic Apoptotic Signaling Pathway (GO:0097193),1/105,0.344227687389332,0.404736460563238,0,0,2.41187925998053,2.57215336073768,PML
Regulation Of Neuron Apoptotic Process (GO:0043523),1/105,0.344227687389332,0.404736460563238,0,0,2.41187925998053,2.57215336073768,CCL2
Lysosomal Transport (GO:0007041),1/105,0.344227687389332,0.404736460563238,0,0,2.41187925998053,2.57215336073768,DTX3L
Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045),1/106,0.346864616122974,0.40704190819889,0,0,2.38878842676311,2.52929870687008,CCL2
Regulation Of Cellular Response To Stress (GO:0080135),1/107,0.349491073432277,0.407430784741803,0,0,2.36613326964414,2.48746209719552,BRCA2
Positive Regulation Of T Cell Activation (GO:0050870),1/107,0.349491073432277,0.407430784741803,0,0,2.36613326964414,2.48746209719552,CCL2
Positive Regulation Of Autophagy (GO:0010508),1/107,0.349491073432277,0.407430784741803,0,0,2.36613326964414,2.48746209719552,TRIM22
Positive Regulation Of Intracellular Signal Transduction (GO:1902533),3/525,0.350754238619475,0.407430784741803,0,0,1.44782803403493,1.51684523721468,EIF2AK2;TRIM22;BIRC3
Positive Regulation Of Translation (GO:0045727),1/108,0.352107100496036,0.407430784741803,0,0,2.34390157340589,2.44661107523322,SAMD4A
Positive Regulation Of DNA Metabolic Process (GO:0051054),1/108,0.352107100496036,0.407430784741803,0,0,2.34390157340589,2.44661107523322,PML
Response To Tumor Necrosis Factor (GO:0034612),1/108,0.352107100496036,0.407430784741803,0,0,2.34390157340589,2.44661107523322,CCL2
Positive Regulation Of MAPK Cascade (GO:0043410),2/310,0.352610363539002,0.407430784741803,0,0,1.63270063270063,1.70191345370429,CCL2;EIF2AK2
Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032434),1/109,0.35471273812632,0.408292673713278,0,0,2.32208157524613,2.40671449508126,RNF144A
Cell-Matrix Adhesion (GO:0007160),1/109,0.35471273812632,0.408292673713278,0,0,2.32208157524613,2.40671449508126,SIGLEC1
RNA Metabolic Process (GO:0016070),1/111,0.359893007999632,0.411892758204902,0,0,2.27963176064442,2.32966623943492,ADARB1
Cytoskeleton Organization (GO:0007010),1/111,0.359893007999632,0.411892758204902,0,0,2.27963176064442,2.32966623943492,CCL2
Double-Strand Break Repair Via Homologous Recombination (GO:0000724),1/111,0.359893007999632,0.411892758204902,0,0,2.27963176064442,2.32966623943492,BRCA2
Protein Deubiquitination (GO:0016579),1/112,0.362467721201895,0.413268121521857,0,0,2.25898049948683,2.29245825980257,USP18
Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071900),1/112,0.362467721201895,0.413268121521857,0,0,2.25898049948683,2.29245825980257,HERC5
Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),4/763,0.364622519165654,0.414511874168557,0,0,1.32868733097566,1.34050288850006,ETV7;IFI27;STAT1;PARP9
Regulation Of Protein Ubiquitination (GO:0031396),1/113,0.365032207029058,0.414511874168557,0,0,2.23869801084991,2.25609200231562,BIRC3
Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),2/319,0.365624261102166,0.414511874168557,0,0,1.58561837741648,1.59536847470548,IFI27;PML
Regulation Of Cytoskeleton Organization (GO:0051493),1/114,0.367586505567171,0.4151727511284,0,0,2.21877450431276,2.22054197726624,NEXN
Protein Modification By Small Protein Removal (GO:0070646),1/114,0.367586505567171,0.4151727511284,0,0,2.21877450431276,2.22054197726624,USP18
Endoplasmic Reticulum To Golgi Vesicle-Mediated Transport (GO:0006888),1/115,0.370130656779633,0.417263399590522,0,0,2.19920053297801,2.18578367070219,PGAP1
Regulation Of Small GTPase Mediated Signal Transduction (GO:0051056),1/118,0.377702623803558,0.424210782704742,0,0,2.14248620577734,2.08602762887741,CD2AP
Ribonucleoprotein Complex Biogenesis (GO:0022613),1/118,0.377702623803558,0.424210782704742,0,0,2.14248620577734,2.08602762887741,IGF2BP3
Protein-Containing Complex Assembly (GO:0065003),2/328,0.378541202477408,0.424360901101303,0,0,1.54113575585968,1.49710605404389,PML;CD2AP
Regulation Of Protein-Containing Complex Assembly (GO:0043254),1/119,0.380206582168749,0.425435617965775,0,0,2.12422226989916,2.05420904393796,EIF2AK2
Protein Localization To Nucleus (GO:0034504),1/122,0.387658914415494,0.432969696619902,0,0,2.07124176169055,1.96276961385925,PML
Modulation Of Chemical Synaptic Transmission (GO:0050804),1/123,0.390123307129289,0.434433637720337,0,0,2.05416061423532,1.93356581092577,OTOF
Negative Regulation Of Growth (GO:0045926),1/124,0.392577905182497,0.434433637720337,0,0,2.03735720901513,1.90497030174551,PML
Neuron Projection Guidance (GO:0097485),1/124,0.392577905182497,0.434433637720337,0,0,2.03735720901513,1.90497030174551,NEXN
Protein Dephosphorylation (GO:0006470),1/124,0.392577905182497,0.434433637720337,0,0,2.03735720901513,1.90497030174551,PPM1K
Positive Regulation Of Defense Response (GO:0031349),1/124,0.392577905182497,0.434433637720337,0,0,2.03735720901513,1.90497030174551,GBP5
Negative Regulation Of Cell Growth (GO:0030308),1/125,0.3950227471324,0.436337052795788,0,0,2.02082482645978,1.87696620333999,PML
Cellular Response To Starvation (GO:0009267),1/126,0.397457871195082,0.438222781061244,0,0,2.00455696202532,1.84953722528903,EIF2AK2
Protein Homooligomerization (GO:0051260),1/129,0.404705316914886,0.444585037924747,0,0,1.95727848101266,1.77054645953623,GBP5
Regulation Of DNA Repair (GO:0006282),1/129,0.404705316914886,0.444585037924747,0,0,1.95727848101266,1.77054645953623,PML
Synapse Organization (GO:0050808),1/131,0.409489053340305,0.449020783444197,0,0,1.9269717624148,1.72048731097167,AGRN
Circulatory System Development (GO:0072359),1/132,0.411866666004323,0.450806787153822,0,0,1.91216542661127,1.69619706550839,HEG1
Non-Membrane-Bounded Organelle Assembly (GO:0140694),1/135,0.418942928509625,0.45771986018656,0,0,1.86907235972039,1.6261314131294,RNF213
Protein Localization To Organelle (GO:0033365),1/137,0.423613659972373,0.461984462506102,0,0,1.84139985107967,1.58163986879693,GBP5
Intracellular Calcium Ion Homeostasis (GO:0006874),1/139,0.428247312004533,0.466193276359365,0,0,1.81452944413869,1.53881971259028,PML
Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),2/364,0.429061896647618,0.466236934624307,0,0,1.38532370024083,1.17219731386847,DTX3L;RIGI
Negative Regulation Of Wnt Signaling Pathway (GO:0030178),1/140,0.430550324153447,0.467011342595271,0,0,1.80138420908843,1.51801037755527,RNF213
Axon Guidance (GO:0007411),1/149,0.450869475925109,0.488171626810999,0,0,1.6910708176531,1.34706878116077,NEXN
DNA Damage Response (GO:0006974),2/384,0.456212645796533,0.493070040878838,0,0,1.31145120150356,1.02922198455724,DTX3L;PML
Cellular Response To Organic Cyclic Compound (GO:0071407),1/152,0.457482101445071,0.493555958906689,0,0,1.6572218962193,1.29597655332136,CCL2
Epithelium Development (GO:0060429),1/154,0.461846769071593,0.497042136680755,0,0,1.63539339786548,1.26337756100073,STAT1
Positive Regulation Of Response To External Stimulus (GO:0032103),1/155,0.464016081087349,0.497042136680755,0,0,1.62469176393227,1.24749693872015,GBP5
Cellular Response To Growth Factor Stimulus (GO:0071363),1/155,0.464016081087349,0.497042136680755,0,0,1.62469176393227,1.24749693872015,CCL2
Ribosome Biogenesis (GO:0042254),1/155,0.464016081087349,0.497042136680755,0,0,1.62469176393227,1.24749693872015,IGF2BP3
Peptide Biosynthetic Process (GO:0043043),1/158,0.47047233853782,0.503062784724276,0,0,1.59340482141417,1.20145609719064,IGF2BP3
Regulation Of Macromolecule Metabolic Process (GO:0060255),1/162,0.478961356925254,0.509425330157249,0,0,1.55350263385486,1.14358821955111,IGF2BP3
Protein Autophosphorylation (GO:0046777),1/162,0.478961356925254,0.509425330157249,0,0,1.55350263385486,1.14358821955111,EIF2AK2
Mitochondrion Organization (GO:0007005),1/162,0.478961356925254,0.509425330157249,0,0,1.55350263385486,1.14358821955111,IFIT2
Membrane Organization (GO:0061024),1/167,0.489383854116682,0.519592734000428,0,0,1.50632911392405,1.07643501574676,OTOF
Heart Development (GO:0007507),1/171,0.497573387858007,0.527357710370634,0,0,1.47058823529412,1.02648855879423,HEG1
Cell-Cell Adhesion Via Plasma-Membrane Adhesion Molecules (GO:0098742),1/172,0.499600420711097,0.528575489047592,0,0,1.46191427936931,1.01449052937942,NEXN
Positive Regulation Of Cellular Biosynthetic Process (GO:0031328),1/174,0.503630289514235,0.531904270679946,0,0,1.44486719836102,0.991052952821063,SAMD4A
Negative Regulation Of Cytokine Production (GO:0001818),1/178,0.511594124647583,0.539368937018993,0,0,1.41192877065008,0.946308115783795,XAF1
Positive Regulation Of ERK1 And ERK2 Cascade (GO:0070374),1/179,0.513565286725902,0.540500529036701,0,0,1.4039254729057,0.935545213100896,CCL2
Phosphorylation (GO:0016310),2/429,0.514535888452712,0.540576971812448,0,0,1.17053984267099,0.777811987401217,CCL2;EIF2AK2
RNA Processing (GO:0006396),1/183,0.521371679580716,0.545853480187115,0,0,1.37279176519683,0.894088424845778,ADARB1
Macromolecule Biosynthetic Process (GO:0009059),1/183,0.521371679580716,0.545853480187115,0,0,1.37279176519683,0.894088424845778,IGF2BP3
Axonogenesis (GO:0007409),1/188,0.530955892219397,0.55492265124319,0,0,1.33574764773573,0.845630214214043,NEXN
Transcription By RNA Polymerase II (GO:0006366),1/192,0.538486595564156,0.56084590057028,0,0,1.30750878123136,0.809338357910124,ETV7
Protein Localization To Membrane (GO:0072657),1/192,0.538486595564156,0.56084590057028,0,0,1.30750878123136,0.809338357910124,AGRN
Regulation Of Cell Differentiation (GO:0045595),1/193,0.540350538130266,0.561815239990363,0,0,1.30063291139241,0.800587947453548,EIF2AK2
Protein Modification Process (GO:0036211),3/711,0.54495384282076,0.565624505824306,0,0,1.05723090468853,0.641796439892535,PGAP1;CCL2;EIF2AK2
Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),2/456,0.547541033628198,0.566554672058032,0,0,1.09940133288151,0.662189072211805,CD38;PML
Golgi Vesicle Transport (GO:0048193),1/197,0.547732257703945,0.566554672058032,0,0,1.2738310514079,0.766806412177273,PGAP1
DNA-templated Transcription (GO:0006351),1/199,0.551379093987284,0.569348567033182,0,0,1.2608362102033,0.750617019647179,ETV7
Regulation Of MAPK Cascade (GO:0043408),1/204,0.560369627131781,0.57764129372146,0,0,1.22946935212322,0.712057828067931,EIF2AK2
Positive Regulation Of Cell Population Proliferation (GO:0008284),2/483,0.578978991543039,0.595804022066512,0,0,1.0362492670185,0.566298914908491,STAT1;IL31RA
Protein Phosphorylation (GO:0006468),2/500,0.597955049270891,0.614281466998424,0,0,1,0.51423969630012,CCL2;EIF2AK2
Regulation Of Cell Growth (GO:0001558),1/227,0.599486969230028,0.614806057029773,0,0,1.10305813823233,0.564413936249225,PML
Chromatin Remodeling (GO:0006338),1/228,0.601107408286266,0.615419489435939,0,0,1.09814308816149,0.558934674869427,DTX3L
Negative Regulation Of Multicellular Organismal Process (GO:0051241),1/231,0.605929980198077,0.61930364699362,0,0,1.08365437534397,0.542900919908659,BRCA2
Translation (GO:0006412),1/234,0.610694967537668,0.623115882131654,0,0,1.06953876242734,0.527451253966861,IGF2BP3
Regulation Of Autophagy (GO:0010506),1/241,0.621593130650027,0.633162545941314,0,0,1.0379746835443,0.493525336044833,TRIM22
Regulation Of ERK1 And ERK2 Cascade (GO:0070372),1/244,0.626171029030573,0.636748242358792,0,0,1.02500390686045,0.479836858205327,CCL2
Positive Regulation Of Apoptotic Process (GO:0043065),1/270,0.663622639276016,0.673694483716967,0,0,0.924709425438803,0.379169337336234,IFIT2
Plasma Membrane Bounded Cell Projection Assembly (GO:0120031),1/275,0.670387824780182,0.679416617033114,0,0,0.907604176291232,0.362949903662576,CD2AP
Positive Regulation Of Cell Differentiation (GO:0045597),1/283,0.680933679951333,0.688944664421349,0,0,0.881497441422031,0.33875097249093,IFITM1
Supramolecular Fiber Organization (GO:0097435),1/316,0.721024653291808,0.728283290741054,0,0,0.787823990355636,0.257683006304785,CD2AP
Protein Localization (GO:0008104),1/351,0.75811476926876,0.764464139195634,0,0,0.707775768535262,0.195997615574709,HEG1
Positive Regulation Of Multicellular Organismal Process (GO:0051240),1/387,0.79118230783753,0.796474497187614,0,0,0.64058503312127,0.15004222093484,EIF2AK2
Vesicle-Mediated Transport (GO:0016192),1/411,0.810704320681896,0.814764609433224,0,0,0.602346403210868,0.126403523578995,DTX3L
Organelle Organization (GO:0006996),1/418,0.816050718430113,0.818770887491547,0,0,0.592022584464074,0.120345623380438,CCL2
Nervous System Development (GO:0007399),1/433,0.827010250482075,0.82838630747123,0,0,0.571026722925457,0.108459781769507,IGF2BP3
Positive Regulation Of Cellular Process (GO:0048522),1/594,0.910796130754011,0.910796130754011,0,0,0.412555766644609,0.0385476402295189,IL31RA
